Published Research Papers

Published Research Papers2024-02-09T19:04:20-05:00

On this page

Publications from CITF-funded research

Richard L, Nisenbaum R, Colwill K, Mishra S, Dayam RM, Liu M, Pedersen C, Gingras A, Hwang SW. Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada. BMC Infectious Diseases. 2 February 2024; doi: https://doi.org/10.1186/s12879-024-09013-9

Allen UD, Barton M, Upton J, Bailey A, Campigotto A, Abdulnoor M, Julien JP, Gubbay J, Kissoon N, Litosh A, La Neve R, Wong P, Allen A, Bailey R, Byrne W, Jagoowani R, Phillips C, Merreles-Pulcini M, Polack A, Prescod C, Siddiqi A, Summers A, Thompson K, Thompson S, James, C. Disproportionate rates of COVID19 among Black Canadian communities: lessons from a crosssectional study in the first year of the pandemic. Journal of Racial and Ethnic Disparities. 2024 January 22; doi: https://doi.org/10.1007/s40615-023-01903-z

Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, Kam A, Emsley J, Gravel J, Porter R, Sabhaney V, Mater A, Salvadori M, Berthelot S, Beer D, Poonai N, Moffat A, Wright B, Freedman SB, Pediatric Emergency Research Canada (PERC) COVID Study Group. Comparison of symptoms associated With SARS-CoV-2 variants among children in Canada. JAMA Network Open. March 9, 2023; doi: https://doi.org./10.1001/jamanetworkopen.2023.2328.

Law JC, Watts TH. Considerations for choosing T Cell assays during a pandemic. J Immunol. 2023 Jul 15;211(2):169-174. https://doi.org/doi: 10.4049/jimmunol.2300129.

Hegazy N, Cowan A, D’Aoust PM, Mercier É, Towhid ST, Jia JJ, Wan S, Zhang Z, Kabir MP, Fang W, Graber TE, MacKenzie AE, Guilherme S, Delatolla R. Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic. Sci Total Environ. 2022 Dec 20;853:158458. doi: 10.1016/j.scitotenv.2022.158458.

Djaïleb A, Parker MF, Lavallée E, Stuible M, Durocher Y, Thériault M, Santerre K, Gilbert C, Boudreau D, Baz M, Masson JF, Langlois MA, Trottier S, Quaglia D, Pelletier JN. Longitudinal study on seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through transformation of ELISA datasets. medRxiv. 2024 January 29. doi: https://doi.org/10.1101/2024.01.27.24301877.

Thomas B, Flood CM, Krishnamurthy V, Tanner R and Wilson K. Privacy Rights and Private Sector Vaccination Requirements. Intelligence Memos. 2022 Jan 28. url: https://www.cdhowe.org/sites/default/files/2022-01/IM_Tho-Flo-Kri-Tan-Wil_2022_0128.pdf.

Nantel S, Sheikh-Mohamed S, Y C Chao G, Kurtesi A, Hu Q, Wood H, Colwill K, Li Z, Liu Y, Seifried L, Bourdin B, McGeer A, Hardy WR, Rojas OL, Al-Aubodah TA, Liu Z, Ostrowski MA, Brockman MA, Piccirillo CA, Quach C, Rini JM, Gingras AC, Decaluwe H, Gommerman JL. Comparison of Omicron Breakthrough Infection Versus Monovalent SARS-CoV-2 Intramuscular Booster Reveals Differences in Mucosal and Systemic Humoral Immunity. Mucosal Immunol. 2024 Jan 24:S1933-0219(24)00004-7. doi: 10.1016/j.mucimm.2024.01.004.

Cherry N, Adisesh A, Burstyn I, Charlton C, Chen Y, Durand-Moreau Q, Labrèche F, Ruzycki S, Turnbull L, Zadunayski T, Yasui Y. Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: a prospective cohort study. Vaccine. 2024 January Silverberg SL, Shulha HP, McMillan B, He G, Lee A, Márquez AC, Bartlett SR, Gill V, Abu-Raya B, Bettinger JA, Cabrera A, Coombs D, Gantt S, Goldfarb DM, Sauvé L, Krajden M, Morshed M, Sekirov I, Jassem AN, Sadarangani M. Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults. BMC Infectious Diseases. 2024 January 15. doi; https://doi.org/10.1186/s12879-023-08950-1. 

McLaughlin KJ, Khanna M, Allison PJ, Glogauer M, McNally ME, Quiñonez C, Rock L, Siqueira W, Madathil SA. Investigating the perceptions and experiences of Canadian dentists on dental regulatory bodies’ communications and guidelines during the COVID-19 pandemic. Community Dent Oral Epidemiol. 2024 Jan 8. doi: 10.1111/cdoe.12939.

Parkins MD, Lee BE, Acosta N, Bautista M, Hubert CRJ, Hrudey SE, Frankowski K, Pang XL. Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond. Clinical Microbiology Reviews. 2023 December 14; doi: https://doi.org/10.1128/cmr.00103-22.

Kandasamy S, Chabrotra R, Khan Z, Rana D, Suddle N, Desai D, Khan F, Nocos R, Lear SA, Anand SS. Engaging participants through hybrid community-centered approaches: lessons learned during the COVID CommUNITY public health research program. Health Promot Pract. 2024 Jan 5:15248399231221161. doi: 10.1177/15248399231221161.

Hohl CM, McRae AD. Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances. CMAJ 2022.07.25; doi: https://doi.org/10.1503/cmaj.221012.

Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-Mohammadi K, St-Denis-Bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, McGuinty M, Saginur R, Langlois MA, Cooper CL. Cohort profile: Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination. BMJ Open. August 16, 2022; doi: https://doi.org/10.1136/bmjopen-2022-062187.

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. Four privacy choices for vaccine passports. C.D. Howe Institute Working Paper. 2021 July 12; url: https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-and-wilson-%E2%80%93-four-privacy-choices-vaccine

Galarneau J-M, Labrèche F, Durand-Moreau Q, Ruzycki S, Adisesh A, Burstyn I, Zadunayski T, Cherry N. Excess risk of COVID-19 infection and mental distress in healthcare workers during successive pandemic waves: Analysis of matched cohorts of healthcare workers and community referents in Alberta, Canada. Can J Public Health. 2024 Jan 16. doi: 10.17269/s41997-023-00848-4.

Walmsley S, Nabipoor M, Lovblom LE, Ravindran R, Colwill K, McGeer A, Dayam RM, Manase D, Gingras AC, STOPCoV Team. Predictors of breakthrough SARS-CoV-2 infection after vaccination. Vaccines. 2023 Dec 28;12(1):36. DOI: https://doi.org/10.3390/vaccines12010036

Ismail S, Unger S, Budylowski P, Poutanen S, Yau Y, Jenkins C, Anwer S, Christie-Holmes N, Kiss A, Mazzulli T, Johnstone J, McGeer A, Whittle W, Parvez B, Gray-Owen SD, Stone D, O’Connor DL. SARS-CoV-2 antibodies and their neutralizing capacity against live virus in human milk after COVID-19 infection and vaccination: prospective cohort studies. The American Journal of Clinical Nutrition. 2023 Dec 14. doi: https://doi.org/10.1016/j.ajcnut.2023.10.008

Benoit JM, Breznik JA, Ang JC, Bhakta H, Huynh A, Cowbrough B, Baker B, Heessels L, Lodhi S, Yan E, Ewusie J, Nazy I, Bramson J, Miller MS, Bernatsky S, Larché MJ, Bowdish DME; SUCCEED Investigator Group. Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis. Sci Rep. 2023 Dec 21;13(1):22846. doi: 10.1038/s41598-023-50263-5

Hohl CM, Rosychuk RJ, Hau JP, Hayward J, Landes M, Yan JW, Ting DK, Welsford M, Archambault PM, Mercier E, Chandra K, Davis P, Vaillancourt S, Leeies M, Small S, Morrison LJ; Canadian COVID-19 Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers, for the Canadian Critical Care Trials Group. Treatments, resource utilization, and outcomes of COVID-19 patients presenting to emergency departments across pandemic waves: an observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). CJEM. 2022 Jun;24(4):461-462. doi: https://doi.org/10.1007/s43678-022-00314-z

D’Aoust PM, Towhid ST, Mercier E, Hegazy N, Tian X, Bhatnagar K, Zhang Z, Naughton CC, MacKenzie AE, Graber TE, Delatolla R. COVID-19 wastewater surveillance in rural communities: Comparison of lagoon and pumping station samples. Sc Total Environ. 2021 August 13. doi: https://doi.org/10.1016/j.scitotenv.2021.149618

Cuperlovic-Culf M, Bennet S, Galipeau Y, McCluskie PS, Arnold C, Bagheri S, Cooper CL, Langlois M, Fritz J, Piccirillo C, Crawley AM. Multi-variate statistical and machine learning reveals the interplay between sex and age in antibody responses to de novo SARS-CoV-2 infection and vaccination. bioRxiv. 2023 December 5. doi: https://doi.org/10.1101/2023.12.05.569965

Chanchlani R, Shah BJ, Bangdiwala SI, de Souza R, Luo J, Bolotin S, Bowdish DME, Desai D, Lear AS, Loeb M, Punthakee Z, Sherifali D, Wahi G, Anand SS. COVID-19 vaccine effectiveness among South Asians in Ontario: A test-negative design population-based case-control study. medRxiv. 2023 December 9. doi: https://doi.org/10.1101/2023.12.08.23299660

Brown PE, Fu SH, Newcombe L, Tang X, Nagelkerke N, Birnboim H C, Bansal A, Colwill K, Mailhot G, Delgado-Brand M, Tursun T, Qi F, Gingras AC, Slutsky AS, Pasic M D, Companion J, Bogoch II, Morawski E, Lam T, Reid A, Jha P, Ab-C Study Collaborators. Hybrid immunity from SARS-CoV-2 infection and vaccination in Canadian adults: cohort study. medRxiv 2023.12.27.23300588; doi: https://doi.org/10.1101/2023.12.27.23300588

Ruzycki S, Adisesh A, Burstyn I, Durand-Moreau Q, Labreche F, Zadunayski T, Cherry N. Availability, use, and impact of workplace mental health supports during the COVID-19 pandemic in a Canadian cohort of healthcare workers. medRxiv 2023.12.12.23299862; doi: https://doi.org/10.1101/2023.12.12.23299862

Duong S, Burtniak J, Gretchen A, Mai A, Klassen P, Wei Y, Loeppky, Shaw SY, Bullard, Caeseele PV, Stein DR. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020–February 2022. BMC Public Health. 2023 December 5; doi: https://doi.org/10.1186/s12889-023-17239-6

Halvorson T, Ivison S, Huang Q, Ladua G, Yotis DM, Mannar D, Subramaniam S, Ferreira VH, Kumar D, Belga S, Levings MK. SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain. Transplantation. 2023 November 28; doi: 10.1097/TP.0000000000004873

Asamoah-Boaheng M, Grunau B, Karim ME, Jassem AN, Bolster J, Marquez AC, Scheuermeyer FX, Goldfarb DM. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Front Immunol. 2022 Sep 8;13:954093. doi: https://doi.org/10.3389/fimmu.2022.954093

Wilson M, Qiu Y, Yu J, Lee BE, McCarthy DT, Pang X. Comparison of Auto Sampling and Passive Sampling Methods for SARS-CoV-2 Detection in Wastewater. Pathogens. 2022 Mar 16;11(3):359. doi: https://doi.org/10.3390/pathogens11030359

Hohl CM, Hau JP, Vaillancourt S, Grant J, Brooks SC, Morrison LJ, Perry JJ, Rosychuk RJ; CCEDRRN investigators for the Network of Canadian Emergency Researchers and the Canadian Critical Care Trials Group. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital. JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: https://doi.org/10.1001/jamanetworkopen.2022.36288

Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O’Brien SF, Lavoie P, Grunau B. Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity. Cureus. 2023 Jan 31;15(1):e34465. doi: https://doi.org/10.7759/cureus.34465

Khanna M, Allison P, Farmer J, Quiñonez C, Glogauer M, Siqueira WL, Rock LD, McNally M, Madathil S. Personal protective equipment during COVID-19. JADA. 2023 December; doi: https://doi.org/10.1016/j.adaj.2023.09.017

Richard L, Nisenbaum R, Brown M, Liu M, Pedersen C, Jenkinson JIR, Mishra S, Baral S, Colwill K, Gingras AC, McGeer A, Hwang SW. Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada. JAMA Network Open. 13 March 2023;6(3):e232774; doi: 10.1001/jamanetworkopen.2023.2774

Roushani J, Thomas D, Oliver MJ, Ip J, Yeung A, Tang Y, Brimble KS, Levin A, Hladunewich MA, Cooper R, Blake PG. Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics. CJAN. 18 April 2023;18:465-474; doi: 10.2215/CJN.0000000000000087

Lee DID, Vanderhout S, Aglipay M, Birken CS, Morris SK, Piché‑Renaud, Keown-Stoneman CDG, Maguire JL. Delay in childhood vaccinations during the COVID‑19 pandemic. Canadian Journal of Public Health. 2022 Jan 20;113:126-134. doi: https://doi.org/10.17269/s41997-021-00601-9

Rhodes JS, Aumon A, Morin S, Girard M, Larochelle C, Lahav B, Brunet-Ratnasingham E, Pagliuzza A, Machitto L, Zhang W, Cutler A, Grand’Maison F, Zhou A, Finzi A, Chomont N, Kaufmann DE, Zandee S, Prat A, Wolf G, Moon KR. Gaining Biological Insights through Supervised Data Visualization. medRxiv. January 21, 2024; doi: https://doi.org/10.1101/2023.11.22.568384

Kandola K. Age-stratified SARS-CoV-2 Serological Prevalence Estimation Using Anonymized Residual Sera Following Delta and Omicron Waves in the Northwest Territories (NWT). Unpublished results. 2023 Nov 22

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults. Clin Infect Dis. 2023 Nov 24:ciad716. doi: https://doi.org/10.1093/cid/ciad716

Abu-Raya B, Reicherz F, Michalski C, Majdoubi A, Golding L, Vienta M, Granoski M, Stojic A, Marchant DJ, Lavoie PM. Loss of severe respiratory syncytial virus infection-associated antibody function during the peak of the COVID-19 pandemic mitigation measures. medRxiv. 2023:2023.07.30.23292881. doi: 10.1101/2023.07.30.23292881

Abu-Raya B, Reicherz F, Michalski C, Viñeta Paramo M, Majdoubi A, Golding L, Granoski M, Stojic A, Marchant DJ, Lavoie PM. Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures. J Pediatric Infect Dis Soc. 2023. doi: 10.1093/jpids/piad099

Adisesh A, Durand-Moreau Q, Labrèche F, Ruzycki S, Zadunayski T, Cherry N. Determinants of sickness absence duration after mild COVID-19 in a prospective cohort of Canadian health care workers. J Occup Environ Med. 2023. doi: 10.1097/jom.0000000000002945

Aglipay M, Maguire J, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken C, Kwong JC. mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. medRxiv. 2023:2023.06.27.23291933. doi: 10.1101/2023.06.27.23291933

Alexandrova Y, Yero A, Mboumba Bouassa R-S, Comeau E, Samarani S, Brumme ZL, Hull M, Crawley AM, Langlois M-A, Angel JB, Cooper CL, Needham J, Lee T, Singer J, Anis AH, Costiniuk CT, Jenabian M-A. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses. 2023;15(2):575. doi: 10.3390/v15020575

Archambault PM, Rosychuk RJ, Audet M, Bola R, Vatanpour S, Brooks SC, Daoust R, Clark G, Grant L, Vaillancourt S, Welsford M, Morrison LJ, Hohl CM. Accuracy of Self-Reported COVID-19 Vaccination Status Compared With a Public Health Vaccination Registry in Québec: Observational Diagnostic Study. JMIR Public Health Surveill. 2023;9:e44465. doi: 10.2196/44465

Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O’Brien SF, Lavoie P, Grunau B. Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity. Cureus. 2023;15(1):e34465. doi: 10.7759/cureus.34465

Atiquzzaman M, Zheng Y, Er L, Djurdjev O, Singer J, Krajden M, Balamchi S, Thomas D, Hladunewich M, Oliver MJ, Levin A. COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces. Can J Kidney Health Dis. 2023;10:20543581231181032. doi: 10.1177/20543581231181032

Atkinson A, Albert A, McClymont E, Andrade J, Beach L, Bolotin S, Boucoiran I, Bullard J, Charlton C, Crane J, Dougan S, Forest JC, German GJ, Giguère Y, Girouard G, Hankins C, Krajden M, Lang A, Levett P, Minion J, Neudorf C, Poliquin V, Robinson JL, Scott H, Stein DR, Tran V, Zahariadis G, Zhou HY, Money D. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study. CMAJ Open. 2023;11(2):E305-e13. doi: 10.9778/cmajo.20220045

Azeez R, Lotoski L, Winsor GL, Arnold CR, Galipeau Y, Pelchat M, Goguen S, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Patrick DM, Bullard J, Lix LM, Doucas N, Rodriguez N, Brinkman FSL, Subbarao P, Langlois M-A, Azad M. Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort. medRxiv. 2023:2023.09.06.23294696. doi: 10.1101/2023.09.06.23294696

Bazin R, Rochette S, Perreault J, Fournier MJ, Grégoire Y, Boivin A, Lewin A, Germain M, Renaud C. Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population. Infect Dis (Lond). 2023:1-6. doi: 10.1080/23744235.2023.2195938

Bobrovitz N, Noël K, Li Z, Cao C, Deveaux G, Selemon A, Clifton DA, Yanes-Lane M, Yan T, Arora RK. SeroTracker-RoB: A decision rule-based algorithm for reproducible risk of bias assessment of seroprevalence studies. Res Synth Methods. 2023;14(3):414-26. doi: 10.1002/jrsm.1620.

Bodner K, Irvine MA, Kwong JC, Mishra S. Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies. Int J Infect Dis. 2023. doi: 10.1016/j.ijid.2023.03.022

Bola R, Sutherland J, Murphy RA, Leeies M, Grant L, Hayward J, Archambault P, Graves L, Rose T, Hohl C. Patient-reported health outcomes of SARS-CoV-2-tested patients presenting to emergency departments: a propensity score-matched prospective cohort study. Public Health. 2023;215:1-11. doi: 10.1016/j.puhe.2022.11.016

Boucher E, Cao C, D’Mello S, Duarte N, Donnici C, Duarte N, Bennett G, Adisesh A, Arora R, Kodama D, Bobrovitz N. Occupation and SARS-CoV-2 seroprevalence studies: a systematic review. BMJ Open. 2023;13(2):e063771. doi: 10.1136/bmjopen-2022-063771

Breznik JA, Rahim A, Kajaks T, Hagerman M, Bilaver L, Colwill K, Dayam RM, Gingras AC, Verschoor CP, McElhaney JE, Bramson JL, Bowdish DME, Costa AP. Protection From Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada. J Am Med Dir Assoc. 2023. doi: 10.1016/j.jamda.2023.02.105

Breznik JA, Rahim A, Zhang A, Ang J, Stacey HD, Bhakta H, Clare R, Liu L-M, Kennedy A, Hagerman M, Kajaks T, Miller MS, Nazy I, Bramson JL, Costa AP, Bowdish DME. Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities. eClinicalMedicine. 2023. doi: 10.1016/j.eclinm.2023.102148

Brunet-Ratnasingham E, Morin S, Randolph HE, Labrecque M, Bélair J, Lima-Barbosa R, Pagliuzza A, Marchitto L, Hultström M, Niessl J, Cloutier R, Flores AMS, Brassard N, Benlarbi M, Prévost J, Ding S, Anand SP, Sannier G, Bareke E, Zeberg H, Lipcsey M, Frithiof R, Larsson A, Zhou S, Nakanishi T, Morrison D, Vezina D, Bourassa C, Gendron-Lepage G, Medjahed H, Point F, Richard J, Larochelle C, Prat A, Arbour N, Durand M, Richards JB, Moon K, Chomont N, Finzi A, Tétreault M, Barreiro L, Wolf G, Kaufmann DE. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity. medRxiv. 2023:2023.06.14.23290814. doi: 10.1101/2023.06.14.23290814

Buchan SA, Alley S, Seo CY, Johnson C, Kwong JC, Nasreen S, Thampi N, Lu D, Harris TM, Calzavara A, Wilson SE. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada. JAMA Pediatr. 2023. doi: 10.1001/jamapediatrics.2022.6166.

Burrows AG, Linton S, Thiele J, Sheth PM, Evans GA, Archer S, Doliszny KM, Finlayson M, Flynn L, Huang Y, Kasmani A, Hugh Guan T, Maier A, Hansen-Taugher A, Moore K, Sanfilippo A, Snelgrove-Clarke E, Tripp DA, Walker DMC, Vanner S, Ellis AK. Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting. Allergy, Asthma & Clinical Immunology. 2023;19(1):25. doi: 10.1186/s13223-023-00769-4.

Cheng B, Loeschnik E, Selemon A, Hosseini R, Yuan J, Ware H, Ma X, Cao C, Bergeri I, Subissi L, Lewis HC, Williamson T, Ronksley P, Arora RK, Whelan M, Bobrovitz N. Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic. medRxiv. 2023:2023.06.02.23290895. doi: 10.1101/2023.06.02.23290895.

Cherry N, Adisesh A, Burstyn I, Charlton C, Chen Y, Durand-Moreau Q, Labrèche F, Ruzycki S, Turnbull L, Zadunayski T, Yasui Y. Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: a prospective cohort study. medRxiv. 2023:2023.09.12.23295445. doi: 10.1101/2023.09.12.23295445.

Cherry N, Adisesh A, Burstyn I, Durand-Moreau Q, Galarneau JM, Labrèche F, Ruzycki SM, Zadunayski T. Cohort profile: recruitment and retention in a prospective cohort of Canadian healthcare workers during the COVID-19 pandemic. BMJ Open. 2023;13(11):e074716. doi: 10.1136/bmjopen-2023-074716.

Cherry N, Mhonde T, Adisesh A, Burstyn I, Durand-Moreau Q, Labrèche F, Ruzycki S. The evolution of workplace risk for Covid-19 in Canadian healthcare workers and its relation to vaccination: A nested case-referent study. Am J Ind Med. 2023. doi: 10.1002/ajim.23466.

Cheung MW, Dayam RM, Shapiro JR, Law JC, Chao GYC, Pereira D, Goetgebuer RL, Croitoru D, Stempak JM, Acheampong L, Rizwan S, Lee JD, Jacob L, Ganatra D, Law R, Rodriguez-Castellanos VE, Kern-Smith M, Delgado-Brand M, Mailhot G, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Watts TH, Gingras AC. Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases. Journal of immunology (Baltimore, Md : 1950). 2023. doi: 10.4049/jimmunol.2300190.

Cheung PK, Lapointe HR, Sang Y, Ennis S, Mwimanzi F, Speckmaier S, Barad E, Dong W, Liang R, Simons J, Lowe CF, Romney MG, Brumme CJ, Niikura M, Brockman MA, Brumme ZL. SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART. Aids. 2023. doi: 10.1097/qad.0000000000003519.

Collins E, Galipeau Y, Arnold C, Bhéreur A, Booth R, Buchan CA, Cooper C, Crawley AM, Mccluskie P, McGuinty M, Pelchat M, Rocheleau L, Saginur R, Gravel C, Hawken S, Langlois M-A, Little J. Clinical and Serological predictors of Post-COVID-19 Condition: Findings from a Canadian Prospective Cohort Study. medRxiv. 2023:2023.07.29.23293334. doi: 10.1101/2023.07.29.23293334.

Costiniuk CT, Singer J, Lee T, Galipeau Y, McCluskie PS, Arnold C, Langlois M-A, Needham J, Jenabian M-A, Burchell AN, Samji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouche B, Angel JB, Routy J-P, Cooper CL, Anis AH. Antibody neutralization capacity after COVID-19 vaccination in people with HIV. AIDS. 2023:10.1097/QAD.0000000000003680. doi: 10.1097/qad.0000000000003680.

Costiniuk CT, Singer J, Lee T, Langlois MA, Arnold C, Galipeau Y, Needham J, Kulic I, Jenabian MA, Burchell AN, Shamji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH. COVID-19 vaccine immunogenicity in people with HIV. Aids. 2023;37(1):F1-f10. doi: 10.1097/qad.0000000000003429.

Daroya E, Gaspar M, Grey C, Lessard D, Klassen B, Skakoon-Sparling S, Sinno J, Adam B, Perez-Brumer A, Lachowsky NJ, Sang JM, Hart TA, Cox J, Tan DHS, Grace D. “It’s different for heterosexuals”: exploring cis-heteronormativity in COVID-19 public health directives and its impacts on Canadian gay, bisexual, and queer men. Critical Public Health. 2023:1-11. doi: 10.1080/09581596.2023.2226807.

Daroya E, Grey C, Klassen B, Lessard D, Skakoon-Sparling S, Perez-Brumer A, Adam B, Cox J, Lachowsky NJ, Hart TA, Gervais J, Tan DHS, Grace D. ‘It’s not as good as the face-to-face contact’: A sociomaterialist analysis of the use of virtual care among Canadian gay, bisexual and queer men during the COVID-19 pandemic. Sociol Health Illn. 2023. doi: 10.1111/1467-9566.13686.

Datwani S, Kalikawe R, Mwimanzi F, Speckmaier S, Liang R, Sang Y, Waterworth R, Yaseen F, Lapointe H, Barad E, DeMarco M, Holmes D, Simons J, Montaner J, Romney M, Brumme Z, Brockman M. Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults. Pathogens and Immunity. 2023;8(1):117-35. doi: 10.20411/pai.v8i1.613.

Desgagnés J-S, Désy O, Thivierge M-P, Marcoux M, Béland S, De Serres SA. SARS-Cov-2 Antibody Levels That Confer Immune Protection Based on Neutralization of the Omicron Variant. Transplantation. 2023:10.1097/TP.0000000000004596. doi: 10.1097/tp.0000000000004596.

Fell DB, Dimanlig-Cruz S, Török E, Håberg SE, Regan AK, Kaufman JS, Platt RW, Gravel CA, Bruce L, Shah PS, Wilson K, Sprague AE, Alton GD, Dhinsa T, El-Chaâr D, Buchan SA, Kwong JC, Wilson SE, Dunn SI, MacDonald SE, Barrett J, Okun N, Walker MC. Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study. BMJ Med. 2023;2(1):e000632. doi: 10.1136/bmjmed-2023-000632.

Fell DB, Török E, Sprague AE, Regan AK, Dhinsa T, Alton GD, Dimanlig-Cruz S, MacDonald SE, Buchan SA, Kwong JC, Wilson SE, Håberg SE, Gravel CA, Wilson K, Dunn SI, Shah PS, El-Chaâr D, Barrett J, Walker MC, Okun N, Dougan SD. Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study. Vaccine. 2023. doi: 10.1016/j.vaccine.2023.01.073.

Ferreira VH, Ierullo M, Mavandadnejad F, Kurtesi A, Hu Q, Hardy WR, Hall VG, Pinzon N, Yotis D, Gingras AC, Belga S, Shalhoub S, Hébert MJ, Humar A, Kabbani D, Kumar D. Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study. Clin Infect Dis. 2023. doi: 10.1093/cid/ciad175.

Galarneau J-M, Labrèche F, Durand-Moreau Q, Ruzycki S, Adisesh A, Burstyn I, Zadunayski T, Cherry N. Excess risk of Covid-19 infection and mental distress in healthcare workers during successive pandemic waves. Analysis of matched cohorts of healthcare workers and community referents in Alberta, Canada. medRxiv. 2023:2023.09.12.23295439. doi: 10.1101/2023.09.12.23295439.

Germain M, Lewin A, Bazin R, Dieudé M, Perreault J, Boivin A, Grégoire Y, Renaud C. Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV). BMJ Open. 2023;13(2):e068803. doi: 10.1136/bmjopen-2022-068803.

Grant MD, Bentley K, Fielding CA, Hatfield KM, Ings DP, Harnum D, Wang E, Stanton R, Holder KA. Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies. bioRxiv. 2023:2023.03.09.531709. doi: 10.1101/2023.03.09.531709.

Grant MD, Bentley K, Fielding CA, Hatfield KM, Ings DP, Harnum D, Wang EC, Stanton RJ, Holder KA. Anti-S1 and S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2. JCI insight. 2023. doi: 10.1172/jci.insight.170681.

Grewal R, Buchan SA, Nguyen L, Nasreen S, Austin PC, Brown KA, Gubbay J, Lee N, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada: a Canadian Immunization Research Network (CIRN) Study. The Journal of infectious diseases. 2023. doi: 10.1093/infdis/jiad419.

Grewal R, Buchan SA, Nguyen L, Nasreen S, Austin PC, Brown KA, Gubbay J, Lee N, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC, investigators tCIRNPCN. Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada. medRxiv. 2023:2023.04.11.23288403. doi: 10.1101/2023.04.11.23288403.

Grewal R, Nguyen L, Buchan SA, Wilson SE, Nasreen S, Austin PC, Brown KA, Fell DB, Gubbay JB, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nat Commun. 2023;14(1):1273. doi: 10.1038/s41467-023-36566-1.

Grey C, Sinno J, Zhang H, Daroya E, Skakoon-Sparling S, Klassen B, Lessard D, Hart TA, Cox J, Stewart M, Grace D. Queering Public Health: A Critical Examination of Healthcare Access and Gender Expression among Trans, Nonbinary, and Other Gender Nonconforming People during COVID-19. Health & Social Care in the Community. 2023;2023:6676318. doi: 10.1155/2023/6676318.

Grey C, Tian IL, Skakoon-Sparling S, Daroya E, Klassen B, Lessard D, Gaspar M, Sinno J, Sang JM, Perez-Brumer A, Lachowsky NJ, Moore DM, Jollimore J, Hart TA, Cox J, Grace D. Unpacking racism during COVID-19: narratives from racialized Canadian gay, bisexual, and queer men. Int J Equity Health. 2023;22(1):152. doi: 10.1186/s12939-023-01961-z.

Halima Abubakar CV, Erik Lovblum, Rizani Ravindran, Rosemarie Clarke, Karen Colwill, Roya M Dayam, Anne-Claude Gingras, Sharon Walmsley, on behalf of the STOPCoV Research Team. Feasibility and Acceptability of Self-Collected Dried Blood Spots for SARS-CoV-2 Vaccine Response in Community-Dwelling Elderly: A Large Decentralized Prospective Study. Journal of Community Medicine & Public Health. 2023. doi: 10.29011/2577-2228.100309.

Halvorson T, Ivison S, Huang Q, Ladua G, Yotis DM, Mannar D, Subramaniam S, Ferreira VH, Kumar D, Belga S, Levings MK, group tPs. SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain. medRxiv. 2023:2023.08.14.23293991. doi: 10.1101/2023.08.14.23293991.

Hammond K, Lee T, Vulesevic B, Singer J, Needham J, Burchell AN, Samji H, Walmsley S, Hull M, Jenabian MA, Routy JP, Margolese S, Mandarino E, Anis AH, Cooper CL, Costiniuk CT. Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV. AIDS Res Ther. 2023;20(1):73. doi: 10.1186/s12981-023-00571-7.

Hazlewood GS, Colmegna I, Hitchon C, Fortin PR, Bernatsk S, Clarke AE, Mosher D, Wilson T, Thomas M, Barber C, Harrison M, Bansback N, Proulx L, Richards DP, Kaplan GG. Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases. The Journal of Rheumatology. 2023:jrheum.220697. doi: 10.3899/jrheum.220697.

Hohl CM, Cragg A, Purssel E, McAlister FA, Ting DK, Scheuermeyer F, Stachura M, Grant L, Taylor J, Kanu J, Hau JP, Cheng I, Atzema CL, Bola R, Morrison LJ, Landes M, Perry JJ, Rosychuk RJ. Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study. PloS one. 2023;18(9):e0291580. doi: 10.1371/journal.pone.0291580.

Hutchison SM, González OD-J, Watts A, Oberle E, Gadermann A, Goldfarb DM, Oberlander TF, Lavoie PM, Mâsse LC. Anxiety symptoms, psychological distress, and optimism in school staff: Testing associations with stressors and coping during the second year of the COVID-19 pandemic. Journal of Affective Disorders Reports. 2023;14:100662. doi: 10.1016/j.jadr.2023.100662.

Jorgensen SCJ, Drover SSM, Fell DB, Austin PC, D’Souza R, Guttmann A, Buchan SA, Wilson SE, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy. JAMA Pediatr. 2023. doi: 10.1001/jamapediatrics.2023.4499.

Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D’Souza R, Guttmann A, Brown KA, Buchan SA, Gubbay JB, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. Bmj. 2023;380:e074035. doi: 10.1136/bmj-2022-074035.

Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D’Souza R, Guttmann A, Kwong JC. Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months. JAMA Pediatr. 2023;177(4):427-30. doi: 10.1001/jamapediatrics.2022.6134.

Juwono S, Anato JLF, Kirschbaum AL, Metheny N, Dvorakova M, Skakoon-Sparling S, Moore DM, Grace D, Hart TA, Lambert G, Lachowsky NJ, Jollimore J, Cox J, Maheu-Giroux M. Prevalence, determinants, and trends in the experience and perpetration of intimate partner violence among a cohort of gay, bisexual, and other men who have sex with men in Montréal, Toronto, and Vancouver, Canada (2017-2022). medRxiv. 2023:2023.07.24.23293112. doi: 10.1101/2023.07.24.23293112.

Kabbani D, Yotis DM, Ferreira VH, Shalhoub S, Belga S, Tyagi V, Ierullo M, Kulasingam V, Hébert MJ, West L, Delisle JS, Racine N, De Serres SA, Cardinal H, Dieudé M, Humar A, Kumar D. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study. Open Forum Infect Dis. 2023;10(5):ofad200. doi: 10.1093/ofid/ofad200.

Kandasamy S, Manoharan B, Khan Z, Stennett R, Desai D, Nocos R, Wahi G, Banner D, de Souza RJ, Lear SA, Anand SS. Perceptions of COVID-19 risk, vaccine access and confidence: a qualitative description of South Asians in Canada. BMJ Open. 2023;13(4):e070433. doi: 10.1136/bmjopen-2022-070433.

Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C. Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination. BMJ Open. 2023;13(10):e077714. doi: 10.1136/bmjopen-2023-077714.

Khan AA, Sbihi H, Irvine MA, Jassem AN, Joffres Y, Klaver B, Janjua N, Bharmal A, Ng CH, Wilmer A, Galbraith J, Romney MG, Henry B, Hoang LMN, Krajden M, Hogan CA. Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: A Machine Learning and mechanistic modeling study. medRxiv. 2023:2023.03.06.23286837. doi: 10.1101/2023.03.06.23286837.

Kolbe RJ, Madathil SA, Marin LM, Seth R, Faraj N, Allison PJ, Quiñonez C, Glogauer M, Siqueira WL, Siqueira MF. Salivary Cortisol and Anxiety in Canadian Dentists over 1 Year of COVID-19. J Dent Res. 2023:220345231178726. doi: 10.1177/00220345231178726.

Law JC, Watts TH. Considerations for Choosing T Cell Assays during a Pandemic. Journal of immunology (Baltimore, Md : 1950). 2023;211(2):169-74. doi: 10.4049/jimmunol.2300129.

Lee JJY, Bernatsky S, Kwong JC, Li Q, Kwok TSH, Widdifield J. Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis – A population-based self-controlled case series analysis. J Rheumatol. 2023. doi: 10.3899/jrheum.2023-0355.

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC, investigators CIRNPCN. Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults. medRxiv. 2023:2023.08.24.23294503. doi: 10.1101/2023.08.24.23294503.

Leeies M, Rosychuk RJ, Ismath M, Xu K, Archambault P, Fok PT, Audet T, Jelic T, Hayward J, Daoust R, Chandra K, Davis P, Yan JW, Hau JP, Welsford M, Brooks SC, Hohl CM. Intubation practices and outcomes for patients with suspected or confirmed COVID-19: a national observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). Cjem. 2023;25(4):335-43. doi: 10.1007/s43678-023-00487-1.

Lin K, Xu K, Daoust R, Taylor J, Rosychuk RJ, Hau JP, Davis P, Clark G, McRae AD, Hohl CM. Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study. Cjem. 2023. doi: 10.1007/s43678-022-00440-8.

Lin YJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O’Brien SF, Drews SJ. Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiol Spectr. 2023:e0525622. doi: 10.1128/spectrum.05256-22.

Lu RXZ, Rafatian N, Zhao Y, Wagner KT, Beroncal EL, Li B, Lee C, Chen J, Churcher E, Vosoughi D, Wang Y, Baker A, Trahtemberg U, Li B, Pierro A, Andreazza AC, Santos CCd, Radisic M. Heart-on-a-chip model of immune-induced cardiac dysfunction reveals the role of free mitochondrial DNA and therapeutic effects of endothelial exosomes. bioRxiv. 2023:2023.08.09.552495. doi: 10.1101/2023.08.09.552495.

Ma H, Chan AK, Baral SD, Fahim C, Straus S, Sander B, Mishra S. Which Curve Are We Flattening? The Disproportionate Impact of COVID-19 Among Economically Marginalized Communities in Ontario, Canada, Was Unchanged From Wild-Type to Omicron. Open Forum Infect Dis. 2023;10(1):ofac690. doi: 10.1093/ofid/ofac690.

Maltseva M, Galipeau Y, Renner TM, Deschatelets L, Durocher Y, Akache B, Langlois M-A. Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice. Vaccines. 2023;11(1):30. doi: 10.3390/vaccines11010030.

Markovinović A, Quan J, Herauf M, Hracs L, Windsor JW, Sharifi N, Coward S, Caplan L, Gorospe J, Ernest-Suarez K, Ma C, Panaccione R, Ingram RJM, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG. Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease. Am J Gastroenterol. 2023. doi: 10.14309/ajg.0000000000002337.

Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, Wang JH, Qi F, Tursun T, Kardava L, Chau S, Samaan P, Imran A, Dennis C. Copertino J, Chao G, Choi Y, Reinhard RJ, Kaul R, Heffernan JM, Jones RB, Chun T-W, Moir S, Singer J, Gommerman J, Gingras A-C, Kovacs C, Ostrowski M. Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV. bioRxiv. 2023:2023.06.14.544834. doi: 10.1101/2023.06.14.544834.

McAlister FA, Hau JP, Atzema C, McRae AD, Morrison LJ, Grant L, Cheng I, Rosychuk RJ, Hohl CM. The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada. Sci Rep. 2023;13(1):6635. doi: 10.1038/s41598-023-33569-2.

McClymont E, Atkinson A, Albert A, Av-Gay G, Andrade J, Barrett J, Bogler T, Boucoiran I, Castillo E, D’Souza R, El-Chaâr D, Fadel S, Fell DB, Korchinski I, Kuret V, Ogilvie G, Poliquin V, Sadarangani M, Scott H, Snelgrove JW, Tunde-Byass M, Money D. Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study. Vaccine. 2023. doi: 10.1016/j.vaccine.2023.10.032.

Mittal A, Solera JT, Ferreira VH, Kothari S, Kimura M, Pasic I, Mattsson JI, Humar A, Kulasingam V, Ierullo M, Kumar D, Hosseini-Moghaddam SM. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Transplant Cell Ther. 2023. doi: 10.1016/j.jtct.2023.08.008.

Murmann M, Reed AC, Scott M, Presseau J, Heer C, May K, Ramzy A, Huynh CN, Skidmore B, Welch V, Little J, Wilson K, Brouwers M, Hsu AT. Exploring COVID-19 education to support vaccine confidence amongst the general adult population with special considerations for healthcare and long-term care staff: A scoping review. Campbell Syst Rev. 2023;19(3):e1352. doi: 10.1002/cl2.1352.

Murphy TJ, Swail H, Jain J, Anderson M, Awadalla P, Behl L, Brown PE, Charlton CL, Colwill K, Drews SJ, Gingras A-C, Hinshaw D, Jha P, Kanji JN, Kirsh VA, Lang ALS, Langlois M-A, Lee S, Lewin A, O’Brien SF, Pambrun C, Skead K, Stephens DA, Stein DR, Tipples G, Caeseele PGV, Evans TG, Oxlade O, Mazer BD, Buckeridge DL. The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023. Canadian Medical Association Journal. 2023;195(31):E1030-E7. doi: 10.1503/cmaj.230249.

Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Burns L, Young L, Leung V, Ennis S, Brumme CJ, Montaner JSG, Dong W, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine. Open Forum Infectious Diseases. 2023. doi: 10.1093/ofid/ofad073.

Nantel S, Sheikh-Mohamed S, Chao GYC, Kurtesi A, Hu Q, Wood H, Colwill K, Li Z, Liu Y, Seifried L, Bourdin B, McGeer A, Hardy WR, Rojas OL, Ostrowski MA, Brockman MA, Piccirillo CA, Quach C, Rini JM, Gingras A-C, Decaluwe H, Gommerman JL. Comparison of immunity induced by Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic antibody responses. medRxiv. 2023:2023.09.22.23295541. doi: 10.1101/2023.09.22.23295541.

Naveed Z, Li J, Naus M, García HAV, Wilton J, Janjua NZ. A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients. Int J Infect Dis. 2023. doi: 10.1016/j.ijid.2023.03.027.

Naylor KL, McArthur E, Dixon SN, Kwong JC, Thomas D, Balamchi S, Blake PG, Garg AX, Atiqazaaman M, Hladunewich MA, Levin A, Yeung A, Oliver MJ. Impact of study design on vaccine effectiveness estimates of two mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease. Kidney International. 2023. doi: 10.1016/j.kint.2023.01.009.

Nayyerabadi M, Fourcade L, Joshi SA, Chandrasekaran P, Chakravarti A, Massé C, Paul ML, Houle J, Boubekeur AM, DuSablon C, Boudreau V, Bovan D, Darbinian E, Coleman EA, Vinci S, Routy JP, Hétu PO, Poudrier J, Falcone EL. Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses. Int J Infect Dis. 2023. doi: 10.1016/j.ijid.2023.09.006.

N’Guessan A, Kailasam S, Mostefai F, Poujol R, Grenier JC, Ismailova N, Contini P, De Palma R, Haber C, Stadler V, Bourque G, Hussin JG, Shapiro BJ, Fritz JH, Piccirillo CA. Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis. iScience. 2023;26(8):107394. doi: 10.1016/j.isci.2023.107394.

Norton NJ, Holder KA, Ings DP, Harnum DOA, Russell RS, Grant MD. Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals. Viruses. 2023;15(4):996. doi: 10.3390/v15040996.

Norton NJ, Ings DP, Fifield KE, Barnes DA, Barnable KA, Harnum DOA, Holder KA, Russell RS, Grant MD. Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses. Vaccines. 2023;11(9):1462. doi: 10.3390/vaccines11091462.

O’Brien SF, Goldman M, Drews SJ. An expanded role for blood donor emerging pathogens surveillance. Canadian Medical Association Journal. 2023;195(1):E16-E. doi: 10.1503/cmaj.147635-l.

O’Brien SF, Caffrey N, Yi QL, Bolotin S, Janjua NZ, Binka M, Thanh CQ, Stein DR, Lang A, Colquhoun A, Pambrun C, Reedman CN, Drews SJ. Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health. Microbiol Spectr. 2023:e0335622. doi: 10.1128/spectrum.03356-22.

Parham KA, Kim GN, Richer CG, Ninkov M, Wu K, Saeedian N, Li Y, Rashu R, Barr SD, Arts EJ, Haeryfar SMM, Kang CY, Troyer RM. Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8(+) T cells against SARS-CoV-2 variants. iScience. 2023;26(4):106292. doi: 10.1016/j.isci.2023.106292.

Patel P, Li X, Keown-Stoneman CDG, Vanderloo LM, Kinlin LM, Maguire JL, Birken CS. Changes in Pediatric Movement Behaviors During the COVID-19 Pandemic by Stages of Lockdown in Ontario, Canada: A Longitudinal Cohort Study. Journal of Physical Activity and Health. 2023:1-11. doi: 10.1123/jpah.2022-0393.

Perlman-Arrow S, Loo N, Bobrovitz N, Yan T, Arora RK. A real-world evaluation of the implementation of NLP technology in abstract screening of a systematic review. Res Synth Methods. 2023. doi: 10.1002/jrsm.1636.

Piché-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson K, Kwong JC. COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization. Pediatrics. 2023. doi: 10.1542/peds.2022-059513.

Puyat JH, Fowokan A, Wilton J, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis A, Samji H. Risk of COVID-19 Hospitalization in People Living with HIV and HIV-Negative Individuals and the Role of COVID-19 Vaccination: A Retrospective Cohort Study. Int J Infect Dis. 2023. doi: 10.1016/j.ijid.2023.06.026.

Puyat JH, Wilton J, Fowokan A, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis A, Samji H. COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis. J Int AIDS Soc. 2023;26(10):e26178. doi: 10.1002/jia2.26178.

Rabezanahary H, Gilbert C, Santerre K, Scarrone M, Gilbert M, Theriault M, Brousseau N, Masson J-F, Pelletier JN, Boudreau D, Trottier S, Baz M. Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Quebec, Canada. medRxiv. 2023:2023.09.03.23294976. doi: 10.1101/2023.09.03.23294976.

Ravindran R, Szadkowski L, Lovblom LE, Clarke R, Huang QW, Manase D, Parente L, Walmsley S. Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey. PLOS Digit Health. 2023;2(5):e0000242. doi: 10.1371/journal.pdig.0000242.

Reddon H, Barker B, Bartlett S, Márquez AC, Sekirov I, Jassem A, Morshed M, Clemens A, Beck McGreevy P, Hayashi K, DeBeck K, Krajden M, Milloy MJ, Socías ME. Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada. Sci Rep. 2023;13(1):17930. doi: 10.1038/s41598-023-44069-8.

Richard L, Nisenbaum R, Brown M, Liu M, Pedersen C, Jenkinson JIR, Mishra S, Baral S, Colwill K, Gingras AC, McGeer A, Hwang SW. Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada. JAMA Netw Open. 2023;6(3):e232774. doi: 10.1001/jamanetworkopen.2023.2774.

Ritchie G, Young M, Prystajecky N, Romney MG, Lowe CF, Matic N. Adaptability of single nucleotide polymorphism (SNP)-PCR for subtyping SARS-CoV-2 and a new SNP-PCR for XBB, XBB.1.5, and B.Q.1/B.Q.1.1. Clin Microbiol Infect. 2023. doi: 10.1016/j.cmi.2023.06.014.

Roushani J, Thomas D, Oliver MJ, Ip J, Yeung A, Tang Y, Brimble KS, Levin A, Hladunewich MA, Cooper R, Blake PG. Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics: A Retrospective Provincial Cohort Study. Clin J Am Soc Nephrol. 2023;18(4):465-74. doi: 10.2215/cjn.0000000000000087.

Santerre K, Thériault M, Brousseau N, Rochette S, Pelletier JN, Gilbert C, Masson J-F, Baz M, Boudreau D, Trottier S. Cohort Profile: Prospective Cohort to Study the COVID-19 Immune Response in Retail Workers in Québec, Canada (CISACOV). medRxiv. 2023:2023.08.18.23294172. doi: 10.1101/2023.08.18.23294172.

Seth R, Madathil SA, Siqueira WL, McNally M, Quiñonez CR, Glogauer M, Allison PJ. Validity and reliability of the COVID-19 Anxiety Syndrome Scale in Canadian dentists. Clin Psychol Psychother. 2023. doi: 10.1002/cpp.2877.

Silverberg SL, Shulha HP, McMillan B, He G, Lee A, Márquez AC, Bartlett SR, Gill V, Abu-Raya B, Bettinger JA, Cabrera A, Coombs D, Gantt S, Goldfarb DM, Sauvé L, Krajden M, Morshed M, Sekirov I, Jassem AN, Sadarangani M. Factors associated with severe acute respiratory syndrome-related coronavirus 2 infection in unvaccinated children and young adults. medRxiv. 2023:2023.08.13.23294036. doi: 10.1101/2023.08.13.23294036.

Skakoon-Sparling S, Palma PA, Zahran A, Hart TA, Moore DM, Cox J, Lachowsky NJ, Dvorakova M, Daroya E, Grace D. Loneliness and the sexual behavior of sexual minority men in the context of the COVID-19 pandemic. Social and Personality Psychology Compass. 2023;17(9):e12814. doi: 10.1111/spc3.12814.

Su CY, Zhou S, Gonzalez-Kozlova E, Butler-Laporte G, Brunet-Ratnasingham E, Nakanishi T, Jeon W, Morrison DR, Laurent L, Afilalo J, Afilalo M, Henry D, Chen Y, Carrasco-Zanini J, Farjoun Y, Pietzner M, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Moussa Y, DeLuca C, Duggan N, Schurr E, Brassard N, Durand M, Del Valle DM, Thompson R, Cedillo MA, Schadt E, Nie K, Simons NW, Mouskas K, Zaki N, Patel M, Xie H, Harris J, Marvin R, Cheng E, Tuballes K, Argueta K, Scott I, Greenwood CMT, Paterson C, Hinterberg MA, Langenberg C, Forgetta V, Pineau J, Mooser V, Marron T, Beckmann ND, Kim-Schulze S, Charney AW, Gnjatic S, Kaufmann DE, Merad M, Richards JB. Circulating proteins to predict COVID-19 severity. Sci Rep. 2023;13(1):6236. doi: 10.1038/s41598-023-31850-y.

Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, Kam A, Emsley J, Gravel J, Porter R, Sabhaney V, Mater A, Salvadori MI, Berthelot S, Beer D, Poonai N, Moffatt A, Wright B, Freedman SB. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328. doi: 10.1001/jamanetworkopen.2023.2328.

Tauzin A, Benlarbi M, Medjahed H, Grégoire Y, Perreault J, Gendron-Lepage G, Gokool L, Morrisseau C, Arlotto P, Tremblay C, Kaufmann DE, Martel-Laferrière V, Levade I, Côté M, De Serres G, Bazin R, Finzi A. Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination. Vaccines. 2023;11(2):242. doi: 10.3390/vaccines11020242.

Tauzin A, Nicolas A, Ding S, Benlarbi M, Medjahed H, Chatterjee D, Dionne K, Gong SY, Gendron-Lepage G, Bo Y, Perreault J, Goyette G, Gokool L, Arlotto P, Morrisseau C, Tremblay C, Martel-Laferrière V, De Serres G, Levade I, Kaufmann DE, Côté M, Bazin R, Finzi A. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine. Cell reports. 2023;42(1):111998. doi: 10.1016/j.celrep.2023.111998.

Török E, Dhinsa T, Dimanlig-Cruz S, Alton GD, Sprague AE, Dunn SI, Shah PS, El-Chaâr D, Regan AK, Wilson K, Buchan SA, Kwong JC, Håberg SE, Gravel CA, Okun N, Walker MC, MacDonald SE, Wilson SE, Barrett J, Fell DB. Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy. Human Vaccines & Immunotherapeutics. 2023:2215150. doi: 10.1080/21645515.2023.2215150.

Viñeta Paramo M, Ngo LPL, Abu-Raya B, Reicherz F, Xu RY, Bone JN, Srigley JA, Solimano A, Goldfarb DM, Skowronski DM, Lavoie PM. Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study. The Lancet Regional Health – Americas. 2023;25:100582. doi: 10.1016/j.lana.2023.100582.

Walmsley SL, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A, Graham C, Silva A, Manase D, Maksymowsky P, Parente L, Dayam RM, Simpson J, Pasculescu A, Gingras AC. COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series. iScience. 2023;26(4):106506. doi: 10.1016/j.isci.2023.106506.

Watts AW, Mâsse LC, Goldfarb DM, Irvine MA, Hutchison SM, Muttucomaroe L, Poon B, Barakauskas VE, O’Reilly C, Bosman E, Reicherz F, Coombs D, Pitblado M, O’Brien SF, Lavoie PM. SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada. BMJ Open. 2023;13(6):e071228. doi: 10.1136/bmjopen-2022-071228.

Whelan M, Galipeau Y, White-Al Habeeb N, Konforte D, Abou El Hassan M, Booth RA, Arnold C, Langlois MA, Pelchat M. Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals. Open Forum Infect Dis. 2023;10(8):ofad384. doi: 10.1093/ofid/ofad384.

Wigle J, Hodwitz K, Juando-Prats C, Allan K, Li X, Howard L, Fallon B, Birken CS, Maguire JL, Parsons JA. Parents’ perspectives on SARS-CoV-2 vaccinations for children: a qualitative analysis. Canadian Medical Association Journal. 2023;195(7):E259-E66. doi: 10.1503/cmaj.221401.

Wing S, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, McArthur E, Kwong JC, Perl J, Atiquzzaman M, Yeung A, Yau K, Hladunewich MA, Leis JA, Levin A, Blake PG, Oliver MJ. Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period. Clinical Journal of the American Society of Nephrology. 2023:10.2215/CJN.0000000000000108. doi: 10.2215/cjn.0000000000000108.

Yau K, Enilama O, Levin A, Romney MG, Singer J, Blake P, Perl J, Leis JA, Kozak R, Tsui H, Bolotin S, Tran V, Chan CT, Tam P, Dhruve M, Kandel C, Estrada-Codecido J, Brown T, Siwakoti A, Abe KT, Hu Q, Colwill K, Gingras A-C, Oliver MJ, Hladunewich MA. Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol. Canadian Journal of Kidney Health and Disease. 2023;10:20543581231160511. doi: 10.1177/20543581231160511.

Yau K, Kurtesi A, Qi F, Delgado-Brand M, Tursun TR, Hu Q, Dhruve M, Kandel C, Enilama O, Levin A, Jiang Y, Hardy WR, Yuen DA, Perl J, Chan CT, Leis JA, Oliver MJ, Colwill K, Gingras AC, Hladunewich MA. Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease. Nat Commun. 2023;14(1):6041. doi: 10.1038/s41467-023-41678-9.

Yau K, Tam P, Chan CT, Hu Q, Qi F, Abe KT, Kurtesi A, Jiang Y, Estrada-Codecido J, Brown T, Liu L, Siwakoti A, Leis JA, Levin A, Oliver MJ, Colwill K, Gingras AC, Hladunewich MA. BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients. Clin J Am Soc Nephrol. 2023. doi: 10.2215/cjn.0000000000000328.

Yoo S, Garg E, Elliott LT, Hung RJ, Halevy AR, Brooks JD, Bull SB, Gagnon F, Greenwood C, Lawless JF, Paterson AD, Sun L, Zawati MH, Lerner-Ellis J, Abraham R, Birol I, Bourque G, Garant JM, Gosselin C, Li J, Whitney J, Thiruvahindrapuram B, Herbrick JA, Lorenti M, Reuter MS, Adeoye OO, Liu S, Allen U, Bernier FP, Biggs CM, Cheung AM, Cowan J, Herridge M, Maslove DM, Modi BP, Mooser V, Morris SK, Ostrowski M, Parekh RS, Pfeffer G, Suchowersky O, Taher J, Upton J, Warren RL, Yeung R, Aziz N, Turvey SE, Knoppers BM, Lathrop M, Jones S, Scherer SW, Strug LJ. HostSeq: a Canadian whole genome sequencing and clinical data resource. BMC Genom Data. 2023;24(1):26. doi: 10.1186/s12863-023-01128-3.

Zinszer K, Charland K, Pierce L, Saucier A, Hamelin M, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada. Influenza Other Respir Viruses. 2023;17(8):e13186. doi: 10.1111/irv.13186.

Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin M, Cheriet I, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada. Int J Infect Dis. 2023. doi: 10.1016/j.ijid.2023.03.036.

Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Robbins NF, Orjuela G, Jenkins C, Conrod V, Yi QL, O’Brien SF, Drews SJ. A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021. Microbiol Spectr. 2022;10(3):e0113422. doi: 10.1128/spectrum.01134-22.

Akingbola S, Fernandes R, Borden S, Gilbride K, Oswald C, Straus S, Tehrani A, Thomas J, Stuart R. Early identification of a COVID-19 outbreak detected by wastewater surveillance at a large homeless shelter in Toronto, Ontario. Canadian Journal of Public Health. 2022. doi: 10.17269/s41997-022-00696-8.

Anand SS, Arnold C, Bangdiwala SI, Bolotin S, Bowdish D, Chanchlani R, de Souza RJ, Desai D, Kandasamy S, Khan F, Khan Z, Langlois M-A, Limbachia J, Lear SA, Loeb M, Loh L, Manoharan B, Nakka K, Pelchat M, Punthakee Z, Schulze KM, Williams N, Wahi G. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study. CMAJ Open. 2022;10(3):E599-E609. doi: 10.9778/cmajo.20220031.

Andrew MK, Godin J, LeBlanc J, Boivin G, Valiquette L, McGeer A, McElhaney JE, Hatchette TF, ElSherif M, MacKinnon-Cameron D. Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19. Canadian Geriatrics Journal. 2022;25(2):183-96. doi: 10.5770/cgj.25.546.

Appelbaum J, Arnold DM, Kelton JG, Gernsheimer T, Jevtic SD, Ivetic N, Smith JW, Nazy I. SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Adv. 2022;6(7):2250-3. doi: 10.1182/bloodadvances.2021005050.

Asamoah-Boaheng M, Goldfarb DM, Barakauskas V, Kirkham TL, Demers PA, Karim ME, Lavoie PM, Marquez AC, Jassem AN, Jenneson S, MacDonald C, Grunau B. Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population. Microbiol Spectr. 2022;10(1):e0145421. doi: 10.1128/spectrum.01454-21.

Asamoah-Boaheng M, Goldfarb DM, Karim ME, O’Brien SF, Wall N, Drews SJ, Barakauskas V, Jassem AN, Grunau B. The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults. The Journal of infectious diseases. 2022. doi: 10.1093/infdis/jiac403.

Asamoah-Boaheng M, Grunau B, Karim ME, Jassem AN, Bolster J, Marquez AC, Scheuermeyer FX, Goldfarb DM. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Front Immunol. 2022;13:954093. doi: 10.3389/fimmu.2022.954093.

Atiquzzaman M, Zheng Y, Er L, Djurdjev O, Singer J, Krajden M, Balamchi S, Thomas D, Oliver MJ, Levin A. COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada. Kidney International. 2022. doi: 10.1016/j.kint.2022.08.027.

Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, Goguen S, Medeleanu M, Winsor GL, Brinkman FSL, Cameron EE, Roos L, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Wright K, McNeil D, Patrick DM, Bullard J, Langlois M-A, Arnold CR, Galipeau Y, Pelchat M, Doucas N, Subbarao P, Azad MB. Investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort study: methodology and cohort profile. medRxiv. 2022:2022.10.19.22281242. doi: 10.1101/2022.10.19.22281242.

Banerjee A, Lew J, Kroeker A, Baid K, Aftanas P, Nirmalarajah K, Maguire F, Kozak R, McDonald R, Lang A, Gerdts V, Straus SE, Gilbert L, Li AX, Mozafarihashjin M, Walmsley S, Gingras AC, Wrana JL, Mazzulli T, Colwill K, McGeer AJ, Mubareka S, Falzarano D. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants. Med (N Y). 2022. doi: 10.1016/j.medj.2022.04.002.

Bergeri I, Whelan MG, Ware H, Subissi L, Nardone A, Lewis HC, Li Z, Ma X, Valenciano M, Cheng B, Al Ariqi L, Rashidian A, Okeibunor J, Azim T, Wijesinghe P, Le LV, Vaughan A, Pebody R, Vicari A, Yan T, Yanes-Lane M, Cao C, Clifton DA, Cheng MP, Papenburg J, Buckeridge D, Bobrovitz N, Arora RK, Van Kerkhove MD. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS Med. 2022;19(11):e1004107. doi: 10.1371/journal.pmed.1004107.

Bettinger JA, Irvine MA, Shulha HP, Valiquette L, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Sadarangani M, McGeer A, Isenor JE, Marty K, Soe P, De Serres G. Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network. Clin Infect Dis. 2022. doi: 10.1093/cid/ciac852.

Bettinger JA, Sadarangani M, De Serres G, Valiquette L, Vanderkooi OG, Kellner JD, Muller MP, Top KA, Isenor JE, McGeer A, Marty K. The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada. BMJ Open. 2022;12(1):e051254. doi: 10.1136/bmjopen-2021-051254.

Bhatt M, Plint AC, Tang K, Malley R, Huy AP, McGahern C, Dawson J, Pelchat M, Dawson L, Varshney T, Arnold C, Galipeau Y, Austin M, Thampi N, Alnaji F, Langlois MA, Zemek RL. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study. CMAJ Open. 2022;10(2):E357-e66. doi: 10.9778/cmajo.20220026.

Bhatt M, Zemek RL, Tang K, Malley R, Plint AC, Pham-Huy A, Dawson J, McGahern C, Pelchat M, Arnold C, Galipeau Y, Langlois MA. Antibody Seronegativity in COVID-19 RT-PCR-Positive Children. Pediatr Infect Dis J. 2022. doi: 10.1097/inf.0000000000003573.

Bobrovitz N, Noël K, Li Z, Cao C, Deveaux G, Selemon A, Clifton DA, Yanes-Lane M, Yan T, Arora RK. SeroTracker-RoB: an approach to automating reproducible risk of bias assessment of seroprevalence studies. medRxiv. 2022:2021.11.17.21266471. doi: 10.1101/2021.11.17.21266471.

Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge D, Van Kerkhove M, Piechotta V, Higdon M, Wilder-Smith A, Bergeri I, Feikin D, Arora RK, Patel M, Subissi L. Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression. medRxiv. 2022:2022.10.02.22280610. doi: 10.1101/2022.10.02.22280610.

Bodner K, Knight J, Hamilton MA, Mishra S. Higher contact among vaccinated can be a mechanism for negative vaccine effectiveness. medRxiv. 2022:2022.04.25.22274266. doi: 10.1101/2022.04.25.22274266.

Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME. Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. Journal of immunology (Baltimore, Md : 1950). 2022. doi: 10.4049/jimmunol.2200369.

Brockman MA, Mwimanzi F, Lapointe HR, Sang Y, Agafitei O, Cheung PK, Ennis S, Ng K, Basra S, Lim LY, Yaseen F, Young L, Umviligihozo G, Omondi FH, Kalikawe R, Burns L, Brumme CJ, Leung V, Montaner JSG, Holmes D, DeMarco ML, Simons J, Pantophlet R, Niikura M, Romney MG, Brumme ZL. Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults. The Journal of infectious diseases. 2022;225(7):1129-40. doi: 10.1093/infdis/jiab592.

Brooks SC, Rosychuk RJ, Perry JJ, Morrison LJ, Wiemer H, Fok P, Rowe BH, Daoust R, Vatanpour S, Turner J, Landes M, Ohle R, Hayward J, Scheuermeyer F, Welsford M, Hohl C. Derivation and validation of a clinical decision rule to risk-stratify COVID-19 patients discharged from the emergency department: The CCEDRRN COVID discharge score. J Am Coll Emerg Physicians Open. 2022;3(6):e12868. doi: 10.1002/emp2.12868.

Brown PE, Fu SH, Bansal A, Newcombe L, Colwill K, Mailhot G, Delgado-Brand M, Gingras AC, Slutsky AS, Pasic M, Companion J, Bogoch, II, Morawski E, Lam T, Reid A, Jha P. Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults. New England Journal of Medicine. 2022. doi: 10.1056/NEJMc2202879.

Brumme ZL, Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Duncan MC, Yaseen F, Agafitei O, Ennis S, Ng K, Basra S, Lim LY, Kalikawe R, Speckmaier S, Moran-Garcia N, Young L, Ali H, Ganase B, Umviligihozo G, Harrison Omondi F, Atkinson K, Sudderuddin H, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Romney MG, Barrios R, Guillemi S, Brumme CJ, Pantophlet R, Montaner JSG, Niikura M, Harris M, Hull M, Brockman MA. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. NPJ Vaccines. 2022;7(1):28. doi: 10.1038/s41541-022-00452-6.

Bryan Thomas CMF, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson. Human Rights Legislation and Vaccination Mandates. CD Howe Institute. 2022. https://www.cdhowe.org/sites/default/files/2022-02/IM_Tho-Flo-Kri-Tan-Wil_2022_0204.pdf

Bryan Thomas CMF, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson. Privacy Rights and Private Sector Vaccination Requirements. CD Howe Institute. 2022. https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-wilson-privacy-rights-and-private-sector

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes. JAMA Netw Open. 2022;5(9):e2232760. doi: 10.1001/jamanetworkopen.2022.32760.

Buchan SA, Seo CY, Johnson C, Alley S, Kwong JC, Nasreen S, Calzavara A, Lu D, Harris TM, Yu K, Wilson SE. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada. JAMA Netw Open. 2022;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505.

Butler-Laporte G, Gonzalez-Kozlova E, Su CY, Zhou S, Nakanishi T, Brunet-Ratnasingham E, Morrison D, Laurent L, Afilalo J, Afilalo M, Henry D, Chen Y, Carrasco-Zanini J, Farjoun Y, Pietzner M, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Moussa Y, DeLuca C, Duggan N, Schurr E, Brassard N, Durand M, Del Valle DM, Thompson R, Cedillo MA, Schadt E, Nie K, Simons NW, Mouskas K, Zaki N, Patel M, Xie H, Harris J, Marvin R, Cheng E, Tuballes K, Argueta K, Scott I, Greenwood CMT, Paterson C, Hinterberg M, Langenberg C, Forgetta V, Mooser V, Marron T, Beckmann N, Kenigsberg E, Charney AW, Kim-Schulze S, Merad M, Kaufmann DE, Gnjatic S, Richards JB. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. Clin Proteomics. 2022;19(1):34. doi: 10.1186/s12014-022-09371-z.

Butler-Laporte G, Povysil G, Kosmicki JA, Cirulli ET, Drivas T, Furini S, Saad C, Schmidt A, Olszewski P, Korotko U, Quinodoz M, Çelik E, Kundu K, Walter K, Jung J, Stockwell AD, Sloofman LG, Jordan DM, Thompson RC, Del Valle D, Simons N, Cheng E, Sebra R, Schadt EE, Kim-Schulze S, Gnjatic S, Merad M, Buxbaum JD, Beckmann ND, Charney AW, Przychodzen B, Chang T, Pottinger TD, Shang N, Brand F, Fava F, Mari F, Chwialkowska K, Niemira M, Pula S, Baillie JK, Stuckey A, Salas A, Bello X, Pardo-Seco J, Gómez-Carballa A, Rivero-Calle I, Martinón-Torres F, Ganna A, Karczewski KJ, Veerapen K, Bourgey M, Bourque G, Eveleigh RJ, Forgetta V, Morrison D, Langlais D, Lathrop M, Mooser V, Nakanishi T, Frithiof R, Hultström M, Lipcsey M, Marincevic-Zuniga Y, Nordlund J, Schiabor Barrett KM, Lee W, Bolze A, White S, Riffle S, Tanudjaja F, Sandoval E, Neveux I, Dabe S, Casadei N, Motameny S, Alaamery M, Massadeh S, Aljawini N, Almutairi MS, Arabi YM, Alqahtani SA, Al Harthi FS, Almutairi A, Alqubaishi F, Alotaibi S, Binowayn A, Alsolm EA, El Bardisy H, Fawzy M, Cai F, Soranzo N, Butterworth A, Geschwind DH, Arteaga S, Stephens A, Butte MJ, Boutros PC, Yamaguchi TN, Tao S, Eng S, Sanders T, Tung PJ, Broudy ME, Pan Y, Gonzalez A, Chavan N, Johnson R, Pasaniuc B, Yaspan B, Smieszek S, Rivolta C, Bibert S, Bochud PY, Dabrowski M, Zawadzki P, Sypniewski M, Kaja E, Chariyavilaskul P, Nilaratanakul V, Hirankarn N, Shotelersuk V, Pongpanich M, Phokaew C, Chetruengchai W, Tokunaga K, Sugiyama M, Kawai Y, Hasegawa T, Naito T, Namkoong H, Edahiro R, Kimura A, Ogawa S, Kanai T, Fukunaga K, Okada Y, Imoto S, Miyano S, Mangul S, Abedalthagafi MS, Zeberg H, Grzymski JJ, Washington NL, Ossowski S, Ludwig KU, Schulte EC, Riess O, Moniuszko M, Kwasniewski M, Mbarek H, Ismail SI, Verma A, Goldstein DB, Kiryluk K, Renieri A, Ferreira MAR, Richards JB. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative. PLoS Genet. 2022;18(11):e1010367. doi: 10.1371/journal.pgen.1010367.

Cable J, Fauci A, Dowling WE, Günther S, Bente DA, Yadav PD, Madoff LC, Wang LF, Arora RK, Van Kerkhove M, Chu MC, Jaenisch T, Epstein JH, Frost SDW, Bausch DG, Hensley LE, Bergeron É, Sitaras I, Gunn MD, Geisbert TW, Muñoz-Fontela C, Krammer F, de Wit E, Nordenfelt P, Saphire EO, Gilbert SC, Corbett KS, Branco LM, Baize S, van Doremalen N, Krieger MA, Clemens SAC, Hesselink R, Hartman D. Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report. Ann N Y Acad Sci. 2022. doi: 10.1111/nyas.14898.

Chambers C, Samji H, Cooper CL, Costiniuk CT, Janjua NZ, Kroch AE, Arbess G, Benoit AC, Buchan SA, Chung H, Kendall CE, Kwong JC, Langlois MA, Lee SM, Mbuagbaw L, McCullagh J, Moineddin R, Nambiar D, Walmsley S, Anis A, Burchell AN. COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV. Aids. 2022. doi: 10.1097/qad.0000000000003405.

Cheung MW, Dayam RM, Law JC, Goetgebuer RL, Chao GYC, Finkelstein N, Stempak JM, Pereira D, Croitoru D, Acheampong L, Rizwan S, Lee JD, Ganatra D, Law R, Delgado-Brand M, Mailhot G, Piguet V, Silverberg MS, Watts TH, Gingras A-C, Chandran V. Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases. RMD Open. 2022;8(2):e002622. doi: 10.1136/rmdopen-2022-002622.

Choi A, Mâsse LC, Bardwell S, Kayda I, Zhao Y, Xu YXZ, Markarian A, Coombs D, Macdonald A, Watts AW, Dhillon N, Irvine M, O’Reilly C, Lavoie PM, Goldfarb DM, Mostafa HH. Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021. Microbiology Spectrum. 2022;0(0):e00622-22. doi: 10.1128/spectrum.00622-22.

Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC, Investigators obotCIRNPCN. Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study. Open Forum Infectious Diseases. 2022;9(9). doi: 10.1093/ofid/ofac449.

Coleman BL, Fischer K, Maunder R, Kim J, Straus S, Bondy S, McGeer A. Study of the epidemiology of COVID-19 in Ontario elementary and secondary school education workers: an interim analysis following the first school year. Can J Public Health. 2022;113(2):185-95. doi: 10.17269/s41997-022-00613-z.

Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-Mohammadi K, St-Denis-Bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, McGuinty M, Saginur R, Langlois MA, Cooper CL. Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination. BMJ Open. 2022;12(9):e062187. doi: 10.1136/bmjopen-2022-062187.

Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, Abe KT, Wang JH, Pasculescu A, Maltseva M, Rocheleau L, Pelchat M, Fazel-Zarandi M, Iskilova M, Barrios-Rodiles M, Bennett L, Yau K, Cholette F, Mesa C, Li AX, Paterson A, Hladunewich MA, Goodwin PJ, Wrana JL, Drews SJ, Mubareka S, McGeer AJ, Kim J, Langlois MA, Gingras AC, Durocher Y. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin Transl Immunology. 2022;11(3):e1380. doi: 10.1002/cti2.1380.

Coope RJ, Matic N, Pandoh PK, Corbett RD, Smailus DE, Pleasance S, Lowe CF, Ritchie G, Chorlton SD, Young M, Ally AA, Asano JK, Carlsen RE, Chahal SS, Zhao Y, Holmes DT, Romney MG, Jones SJ, Marra MA. Automated Library Construction and Analysis for High-throughput Nanopore Sequencing of SARS-CoV-2. The Journal of Applied Laboratory Medicine. 2022. doi: 10.1093/jalm/jfac054.

D’Aoust PM, Tian X, Towhid ST, Xiao A, Mercier E, Hegazy N, Jia JJ, Wan S, Kabir MP, Fang W, Fuzzen M, Hasing M, Yang MI, Sun J, Plaza-Diaz J, Zhang Z, Cowan A, Eid W, Stephenson S, Servos MR, Wade MJ, MacKenzie AE, Peng H, Edwards EA, Pang XL, Alm EJ, Graber TE, Delatolla R. Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communities. Sci Total Environ. 2022;853:158547. doi: 10.1016/j.scitotenv.2022.158547.

Daroya E, Grey C, Lessard D, Klassen B, Skakoon-Sparling S, Gaspar M, Perez-Brumer A, Adam B, Lachowsky NJ, Moore D, Sang JM, Lambert G, Hart TA, Cox J, Jollimore J, Tan DHS, Grace D. ‘I did not have sex outside of our bubble’: changes in sexual practices and risk reduction strategies among sexual minority men in Canada during the COVID-19 pandemic. Culture, Health & Sexuality. 2022:1-17. doi: 10.1080/13691058.2022.2139414.

Dayam RM, Law JC, Goetgebuer RL, Chao GY, Abe KT, Sutton M, Finkelstein N, Stempak JM, Pereira D, Croitoru D, Acheampong L, Rizwan S, Rymaszewski K, Milgrom R, Ganatra D, Batista NV, Girard M, Lau I, Law R, Cheung MW, Rathod B, Kitaygorodsky J, Samson R, Hu Q, Hardy WR, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Gingras AC, Watts TH. Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases. JCI insight. 2022. doi: 10.1172/jci.insight.159721.

Demone J, Maltseva M, Nourimand M, Nasr-Sharif M, Galipeau Y, Alarcon EI, Langlois MA, MacLean AM. Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines. PloS one. 2022;17(12):e0277668. doi: 10.1371/journal.pone.0277668.

Donnici C, Ilincic N, Cao C, Zhang C, Deveaux G, Clifton D, Buckeridge D, Bobrovitz N, Arora RK. Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance. Epidemics. 2022;41:100645. doi: 10.1016/j.epidem.2022.100645.

Drews SJ, Abe KT, Hu Q, Samson R, Gingras AC, Colwill K, Rathod B, Wang J, Fazel-Zarandi M, Yi QL, Robinson A, Wood H, Tuite A, Fisman D, Evans DH, Lin YJ, O’Brien SF. Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020. Transfusion. 2022;62(1):37-43. doi: 10.1111/trf.16713.

Drews SJ, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras AC, Yi QL, O’Brien SF. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History. Microbiol Spectr. 2022;10(1):e0226221. doi: 10.1128/spectrum.02262-21.

Duarte N, Yanes-Lane M, Arora RK, Bobrovitz N, Liu M, Bego MG, Yan T, Cao C, Gurry C, Hankins CA, Cheng MP, Gingras AC, Mazer BD, Papenburg J, Langlois MA. Adapting Serosurveys for the SARS-CoV-2 Vaccine Era. Open Forum Infect Dis. 2022;9(2):ofab632. doi: 10.1093/ofid/ofab632.

Fell DB, Dhinsa T, Alton GD, Török E, Dimanlig-Cruz S, Regan AK, Sprague AE, Buchan SA, Kwong JC, Wilson SE, Håberg SE, Gravel CA, Wilson K, El-Chaâr D, Walker MC, Barrett J, MacDonald SE, Okun N, Shah PS, Dougan SD, Dunn S, Bisnaire L. Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes. JAMA. 2022. doi: 10.1001/jama.2022.4255.

Fell DB, Dimanlig-Cruz S, Regan AK, Håberg SE, Gravel CA, Oakley L, Alton GD, Török E, Dhinsa T, Shah PS, Wilson K, Sprague AE, El-Chaâr D, Walker MC, Barrett J, Okun N, Buchan SA, Kwong JC, Wilson SE, Dunn SI, MacDonald SE, Dougan SD. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ. 2022;378:e071416. doi: 10.1136/bmj-2022-071416.

Ferreira VH, Solera JT, Hu Q, Hall VG, Arbol BG, Rod Hardy W, Samson R, Marinelli T, Ierullo M, Virk AK, Kurtesi A, Mavandadnejad F, Majchrzak-Kita B, Kulasingam V, Gingras A-C, Kumar D, Humar A. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings. Nature Communications. 2022;13(1):4489. doi: 10.1038/s41467-022-32235-x.

Fowokan A, Samji H, Puyat J, Janjua N, Wilton J, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Burchell AN, Anis A. Effectiveness of COVID-19 Vaccines in People Living with HIV in British Columbia and comparisons with a matched HIV-Negative Cohort: A Test Negative Design. Int J Infect Dis. 2022. doi: 10.1016/j.ijid.2022.11.035.

Fu Z, Rais Y, Dara D, Jackson D, Drabovich AP. Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics. Analytical Chemistry. 2022. doi: 10.1021/acs.analchem.2c01325.

Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study. BMJ Open. 2022;12(4):e057846. doi: 10.1136/bmjopen-2021-057846.

Grunau B, Goldfarb DM, Asamoah-Boaheng M, Golding L, Kirkham TL, Demers PA, Lavoie PM. Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals. JAMA. 2022;327(3):279-81. doi: 10.1001/jama.2021.21921.

Grunau B, Golding L, Prusinkiewicz MA, Asamoah-Boaheng M, Armour R, Marquez AC, Jassem AN, Barakauskas V, O’Brien SF, Drews SJ, Haig S, Lavoie PM, Goldfarb DM. Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273. Microbiol Spectr. 2022:e0270221. doi: 10.1128/spectrum.02702-21.

Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM. A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic. Annals of Emergency Medicine. 2022;80(1):38-45. doi: 10.1016/j.annemergmed.2022.03.009.

Grunau B, Prusinkiewicz M, Asamoah-Boaheng M, Golding L, Lavoie PM, Petric M, Levett PN, Haig S, Barakauskas V, Karim ME, Jassem AN, Drews SJ, Sediqi S, Goldfarb DM. Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals. Microbiology Spectrum. 2022;0(0):e01315-22. doi: 10.1128/spectrum.01315-22.

Grunau B, Tom J, Asamoah-Boaheng M, O’Brien SF, Drews SJ, Sediqi S, Lavoie PM, Barakauskas V, Goldfarb DM. Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections. Open Forum Infectious Diseases. 2022;9(8). doi: 10.1093/ofid/ofac349.

Hall VG, Ferreira VH, Wood H, Ierullo M, Majchrzak-Kita B, Manguiat K, Robinson A, Kulasingam V, Humar A, Kumar D. Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nat Immunol. 2022;23(3):380-5. doi: 10.1038/s41590-021-01126-6.

Healey GR, Golding L, Schick A, Majdoubi A, Lavoie PM, Vallance BA. Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination. Gut. 2022. doi: 10.1136/gutjnl-2022-328556.

Hegazy N, Cowan A, D’Aoust PM, Mercier É, Towhid ST, Jia JJ, Wan S, Zhang Z, Kabir MP, Fang W, Graber TE, MacKenzie AE, Guilherme S, Delatolla R. Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic. Sci Total Environ. 2022;853:158458. doi: 10.1016/j.scitotenv.2022.158458.

Hohl CM, Hau JP, Vaillancourt S, Grant J, Brooks SC, Morrison LJ, Perry JJ, Rosychuk RJ. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital. JAMA Netw Open. 2022;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.

Hohl CM, McRae AD. Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances. Canadian Medical Association Journal. 2022;194(28):E996-E7. doi: 10.1503/cmaj.221012.

Hohl CM, Rosychuk RJ, Archambault PM, O’Sullivan F, Leeies M, Mercier É, Clark G, Innes GD, Brooks SC, Hayward J, Ho V, Jelic T, Welsford M, Sivilotti MLA, Morrison LJ, Perry JJ. The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study. CMAJ Open. 2022;10(1):E90-e9. doi: 10.9778/cmajo.20210243.

Hohl CM, Rosychuk RJ, Hau JP, Hayward J, Landes M, Yan JW, Ting DK, Welsford M, Archambault PM, Mercier E, Chandra K, Davis P, Vaillancourt S, Leeies M, Small S, Morrison LJ. Treatments, resource utilization, and outcomes of COVID-19 patients presenting to emergency departments across pandemic waves: an observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). Cjem. 2022;24(4):397-407. doi: 10.1007/s43678-022-00275-3.

Holder KA, Ings DP, Harnum DOA, Russell RS, Grant MD. Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection. NPJ Vaccines. 2022;7(1):122. doi: 10.1038/s41541-022-00546-1.

Hutchison SM, Watts A, Gadermann A, Oberle E, Oberlander TF, Lavoie PM, Mâsse LC. School staff and teachers during the second year of COVID-19: Higher anxiety symptoms, higher psychological distress, and poorer mental health compared to the general population. J Affect Disord Rep. 2022;8:100335. doi: 10.1016/j.jadr.2022.100335.

Ings DP, Hatfield KM, Fifield KE, Harnum DOA, Holder KA, Russell RS, Grant MD. Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation. PloS one. 2022;17(1):e0262957. doi: 10.1371/journal.pone.0262957.

Jantzen R, Maltais M, Broët P. Socio-Demographic Factors Associated With COVID-19 Vaccine Hesitancy Among Middle-Aged Adults During the Quebec’s Vaccination Campaign. Front Public Health. 2022;10:756037. doi: 10.3389/fpubh.2022.756037.

Jenkinson JIR, Sniderman R, Gogosis E, Liu M, Nisenbaum R, Pedersen C, Spandier O, Tibebu T, Dyer A, Crichlow F, Richard L, Orkin A, Thulien N, Kiran T, Kayseas J, Hwang SW. Exploring COVID-19 vaccine uptake, confidence and hesitancy among people experiencing homelessness in Toronto, Canada: protocol for the Ku-gaa-gii pimitizi-win qualitative study. BMJ Open. 2022;12(8):e064225. doi: 10.1136/bmjopen-2022-064225.

Kanji JN, Nguyen LT, Plitt SS, Charlton CL, Fenton J, Braun S, Marohn C, Lau C, Svenson LW, Hinshaw D, Lutsiak C, Zelyas N, Mengel M, Tipples G. Seropositivity to SARS-CoV-2 in Alberta, Canada in a post-vaccination period (March 2021-July 2021). Infect Dis (Lond). 2022:1-11. doi: 10.1080/23744235.2022.2080250.

Kimura M, Ferreira VH, Kothari S, Pasic I, Mattsson JI, Kulasingam V, Humar A, Mah A, Delisle JS, Ierullo M, Majchrzak-Kita B, Kumar D, Hosseini-Moghaddam SM. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Transplant Cell Ther. 2022;28(10):706.e1-.e10. doi: 10.1016/j.jtct.2022.07.024.

Kronfli N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, Park H, Balso LD, Cheng MP, Cox J. Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study. Frontiers in Public Health. 2022;10. doi: 10.3389/fpubh.2022.1021871.

Kronfli N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, Sherman J, Park H, Del Balso L, Cheng MP, Poulin S, Cox J. Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021). Clin Infect Dis. 2022. doi: 10.1093/cid/ciac031.

Kuenzig ME, Widdifield J, Bernatsky S, Kaplan GG, Benchimol EI. Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada. Lancet Gastroenterol Hepatol. 2022;7(4):288-9. doi: 10.1016/s2468-1253(22)00054-1.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Waterworth R, Umviligihozo G, Ennis S, Young L, Dong W, Kirkby D, Burns L, Leung V, Holmes DT, DeMarco ML, Simons J, Matic N, Montaner JSG, Brumme CJ, Prystajecky N, Niikura M, Lowe CF, Romney MG, Brockman MA, Brumme ZL. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination. Frontiers in Immunology. 2022;13. doi: 10.3389/fimmu.2022.947021.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Speckmaier S, Barad E, Moran-Garcia N, Datwani S, Duncan MC, Kalikawe R, Ennis S, Young L, Ganase B, Omondi FH, Umviligihozo G, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, Demarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART. Aids. 2022. doi: 10.1097/qad.0000000000003469.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Speckmaier S, Moran-Garcia N, Datwani S, Duncan MC, Agafitei O, Ennis S, Young L, Ali H, Ganase B, Omondi FH, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes DT, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Pantophlet R, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses. The Journal of infectious diseases. 2022. doi: 10.1093/infdis/jiac229.

Law JC, Girard M, Chao GYC, Ward LA, Isho B, Rathod B, Colwill K, Li Z, Rini JM, Yue FY, Mubareka S, McGeer AJ, Ostrowski MA, Gommerman JL, Gingras AC, Watts TH. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset. Journal of immunology (Baltimore, Md : 1950). 2022;208(2):429-43. doi: 10.4049/jimmunol.2100727.

Lee DID, Vanderhout S, Aglipay M, Birken CS, Morris SK, Piché-Renaud PP, Keown-Stoneman CDG, Maguire JL. Delay in childhood vaccinations during the COVID-19 pandemic. Can J Public Health. 2022;113(1):126-34. doi: 10.17269/s41997-021-00601-9.

Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, Nardone A, Valenciano M, Cheng B, Noel K, Cao C, Yanes-Lane M, Herring BL, Talisuna A, Ngoy N, Balde T, Clifton D, Van Kerkhove MD, Buckeridge D, Bobrovitz N, Okeibunor J, Arora RK, Bergeri I. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Global Health. 2022;7(8):e008793. doi: 10.1136/bmjgh-2022-008793.

Lin J, Law R, Korosec CS, Zhou C, Koh WH, Ghaemi MS, Samaan P, Ooi HK, Matveev V, Yue F, Gingras A-C, Estacio A, Buchholz M, Cheatley PL, Mohammadi A, Kaul R, Pavinski K, Mubareka S, McGeer AJ, Leis JA, Heffernan JM, Ostrowski M. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity. Journal of Virology. 2022;96(13):e00509-22. doi: 10.1128/jvi.00509-22.

Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ. Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Microbiology Spectrum. 2022;0(0):e02811-22. doi: 10.1128/spectrum.02811-22.

Ma H, Yiu KCY, Baral SD, Fahim C, Moloney G, Darvin D, Landsman D, Chan AK, Straus S, Mishra S. COVID-19 Cases Among Congregate Care Facility Staff by Neighborhood of Residence and Social and Structural Determinants: Observational Study. JMIR Public Health Surveill. 2022;8(10):e34927. doi: 10.2196/34927.

Ma X, Li Z, Whelan MG, Kim D, Cao C, Yanes-Lane M, Yan T, Jaenisch T, Chu M, Clifton DA, Subissi L, Bobrovitz N, Arora RK. Serology Assays Used in SARS-CoV-2 Seroprevalence Surveys Worldwide: A Systematic Review and Meta-Analysis of Assay Features, Testing Algorithms, and Performance. Vaccines (Basel). 2022;10(12). doi: 10.3390/vaccines10122000.

Macdonald LK, Glogauer M, Allison P, Quiñonez C, Madathil S, Rock LD. Canadian dental hygienists’ experiences and perceptions of regulatory guidelines during the COVID-19 pandemic: a qualitative descriptive analysis. BMC Health Serv Res. 2022;22(1):1570. doi: 10.1186/s12913-022-08925-z.

Matic N, Lowe CF, Ritchie G, Young M, Lawson T, Romney MG. Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other Variants of Concern and impact on diagnostic testing strategy. Clin Microbiol Infect. 2022. doi: 10.1016/j.cmi.2022.04.022.

McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, Kuret V, Poliquin V, Reeve T, Scott H, Sprague AE, Carson G, Cassell K, Crane J, Elwood C, Joynt C, Murphy P, Murphy-Kaulbeck L, Saunders S, Shah P, Snelgrove JW, van Schalkwyk J, Yudin MH, Money D. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes. JAMA. 2022. doi: 10.1001/jama.2022.5906.

McEvoy CM, Hu Q, Abe KT, Yau K, Oliver MJ, Levin A, Gingras AC, Hladunewich MA, Yuen DA. Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients. Transplant Direct. 2022;9(1):e1401. doi: 10.1097/txd.0000000000001401.

McRae AD, Archambault P, Fok P, Wiemer H, Morrison LJ, Herder M. Reducing barriers to accessing administrative data on SARS-CoV-2 vaccination for research. Cmaj. 2022;194(27):E943-e7. doi: 10.1503/cmaj.211712.

Mercier E, D’Aoust PM, Thakali O, Hegazy N, Jia JJ, Zhang Z, Eid W, Plaza-Diaz J, Kabir MP, Fang W, Cowan A, Stephenson SE, Pisharody L, MacKenzie AE, Graber TE, Wan S, Delatolla R. Municipal and neighbourhood level wastewater surveillance and subtyping of an influenza virus outbreak. Sci Rep. 2022;12(1):15777. doi: 10.1038/s41598-022-20076-z.

Mithani SS, Bota AB, Zhu DT, Wilson K. A scoping review of global vaccine certificate solutions for COVID-19. Hum Vaccin Immunother. 2022;18(1):1-12. doi: 10.1080/21645515.2021.1969849.

Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Datwani S, Omondi FH, Burns L, Young L, Leung V, Agafitei O, Ennis S, Dong W, Basra S, Lim LY, Ng K, Pantophlet R, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose. The Journal of infectious diseases. 2022. doi: 10.1093/infdis/jiac199.

Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin M-È, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine. Frontiers in Immunology. 2022;13. doi: 10.3389/fimmu.2022.930252.

Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. Vaccine. 2022;40(24):3305-12. doi: 10.1016/j.vaccine.2022.04.065.

Nasreen S, Chung H, He S, Brown KA, Gubbay JB, Buchan SA, Fell DB, Austin PC, Schwartz KL, Sundaram ME, Calzavara A, Chen B, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nature microbiology. 2022. doi: 10.1038/s41564-021-01053-0.

Nasreen S, Febriani Y, Velásquez García HA, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC, Investigators obotCIRNPCN. Effectiveness of Coronavirus Disease 2019 Vaccines Against Hospitalization and Death in Canada: A Multiprovincial, Test-Negative Design Study. Clinical Infectious Diseases. 2022. doi: 10.1093/cid/ciac634.

Naveed Z, Li J, Spencer M, Wilton J, Naus M, García HAV, Otterstatter M, Janjua NZ. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. Cmaj. 2022;194(45):E1529-e36. doi: 10.1503/cmaj.220676.

Naveed Z, Li J, Wilton J, Spencer M, Naus M, Velásquez García HA, Kwong JC, Rose C, Otterstatter M, Janjua NZ. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines. J Am Coll Cardiol. 2022;80(20):1900-8. doi: 10.1016/j.jacc.2022.08.799.

Nikiforuk AM, McMillan B, Bartlett SR, Márquez AC, Pidduck T, Kustra J, Goldfarb DM, Barakauskas V, Sinclair G, Patrick DM, Sadarangani M, Ogilvie GS, Krajden M, Morshed M, Sekirov I, Jassem AN. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response. Microbiol Spectr. 2022:e0140521. doi: 10.1128/spectrum.01405-21.

O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ. SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron. Viruses. 2022;14(11):2336. doi: 10.3390/v14112336.

Oliver MJ, Blake PG. Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 2022;17(6):779-81. doi: 10.2215/cjn.04930422.

Oliver MJ, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, McArthur E, Kwong J, Perl J, Atiquzzaman M, Singer J, Yeung A, Hladunewich M, Yau K, Garg AX, Leis JA, Levin A, Krajden M, Blake PG. Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada. J Am Soc Nephrol. 2022;33(4):839-49. doi: 10.1681/asn.2021091262.

Paramo MV, Abu-Raya B, Reicherz F, Xu RY, Bone JN, Srigley JA, Solimano A, Goldfarb DM, Skowronski DM, Lavoie PM. Comparative analysis of pediatric Respiratory Syncytial Virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada. medRxiv. 2022:2022.11.18.22282477. doi: 10.1101/2022.11.18.22282477.

Park H, Linthwaite B, Dussault C, Halavrezos A, Chalifoux S, Sherman J, Del Balso L, Buxton JA, Cox J, Kronfli N. Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada. Int J Prison Health. 2022;ahead-of-print(ahead-of-print). doi: 10.1108/ijph-06-2022-0038.

Pluss O, Campbell H, Pezzi L, Morales I, Roell Y, Quandelacy TM, Arora RK, Boucher E, Lamb MM, Chu M, Bärnighausen T, Jaenisch T. Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data. Int J Epidemiol. 2022. doi: 10.1093/ije/dyac178.

Qiu Y, Yu J, Pabbaraju K, Lee BE, Gao T, Ashbolt NJ, Hrudey SE, Diggle M, Tipples G, Maal-Bared R, Pang X. Validating and optimizing the method for molecular detection and quantification of SARS-CoV-2 in wastewater. Sci Total Environ. 2022;812:151434. doi: 10.1016/j.scitotenv.2021.151434.

Quan J, Ma C, Panaccione R, Hracs L, Sharifi N, Herauf M, Makovinović A, Coward S, Windsor JW, Caplan L, Ingram RJM, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG. Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease. Gut. 2022. doi: 10.1136/gutjnl-2022-327440.

Quan J, Ma C, Panaccione R, Hracs L, Sharifi N, Herauf M, Markovinović A, Coward S, Windsor JW, Caplan L, Ingram RJM, Charlton C, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG. Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2022. doi: 10.1016/s2468-1253(22)00340-5.

Racine É, Boivin G, Longtin Y, McCormack D, Decaluwe H, Savard P, Cheng MP, Hamelin M, Carbonneau J, Tadount F, Adams K, Bourdin B, Nantel S, Gilca V, Corbeil J, De Serres G, Quach-Thanh C. The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers. Influenza Other Respir Viruses. 2022. doi: 10.1111/irv.12997.

Reedman CN, Drews SJ, Yi QL, Pambrun C, O’Brien SF. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era. Microbiol Spectr. 2022:e0033922. doi: 10.1128/spectrum.00339-22.

Reicherz F, Xu RY, Abu-Raya B, Majdoubi A, Michalski C, Golding L, Stojic A, Vineta M, Granoski M, Cieslak Z, Chacko A, Desai N, Sekirov I, Marchant DJ, Lavoie PM. Waning immunity against respiratory syncytial virus during the COVID-19 pandemic. The Journal of infectious diseases. 2022. doi: 10.1093/infdis/jiac192.

Richard L, Liu M, Jenkinson JIR, Nisenbaum R, Brown M, Pedersen C, Hwang SW. COVID-19 Vaccine Coverage and Sociodemographic, Behavioural and Housing Factors Associated with Vaccination among People Experiencing Homelessness in Toronto, Canada: A Cross-Sectional Study. Vaccines. 2022;10(8):1245. doi: 10.3390/vaccines10081245.

Richard L, Nisenbaum R, Liu M, McGeer A, Mishra S, Gingras A-C, Gommerman JL, Sniderman R, Pedersen C, Spandier O, Jenkinson JIR, Baral S, Mejia-Lancheros C, Agarwal A, Jamal AJ, Ostrowski M, Dhalla I, Stewart S, Gabriel M, Brown M, Hester J, Hwang SW. Ku-gaa-gii pimitizi-win, the COVID-19 cohort study of people experiencing homelessness in Toronto, Canada: a study protocol. BMJ Open. 2022;12(8):e063234. doi: 10.1136/bmjopen-2022-063234.

Rock LD, Madathil S, Khanna M, Macdonald LK, Quiñonez C, Glogauer M, Allison P. COVID-19 incidence and vaccination rates among Canadian dental hygienists. Can J Dent Hyg. 2022;56(3):123-30. doi, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674005/

Sadarangani M, Soe P, Shulha HP, Valiquette L, Vanderkooi OG, Kellner JD, Muller MP, Top KA, Isenor JE, McGeer A, Irvine M, De Serres G, Marty K, Bettinger JA. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. The Lancet Infectious Diseases. 2022. doi: 10.1016/S1473-3099(22)00426-1.

Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, Nahass GR, Salomon-Shulman RE, Blacker G, Fazel-Zarandi M, Rathod B, Colwill K, Jamal A, Li Z, de Launay KQ, Takaoka A, Garnham-Takaoka J, Patel A, Fahim C, Paterson A, Li AX, Haq N, Barati S, Gilbert L, Green K, Mozafarihashjin M, Samaan P, Budylowski P, Siqueira WL, Mubareka S, Ostrowski M, Rini JM, Rojas OL, Weissman IL, Tal MC, McGeer A, Regev-Yochay G, Straus S, Gingras AC, Gommerman JL. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 2022:1-10. doi: 10.1038/s41385-022-00511-0.

Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Lau KS, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Nair P, Ho T, Balakrishnan N, Nazy I, Bowdish DM, Svenningsen S, Carlsten C, Mukherjee M. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J. 2022. doi: 10.1183/13993003.00970-2022.

Steinberg N, Allison P, Levin L. Infection Prevention Strategies Concordance in Canadian Dental Schools During the COVID-19 Pandemic. Int Dent J. 2022;72(5):682-90. doi: 10.1016/j.identj.2022.07.005.

Tang X, Sharma A, Pasic M, Brown P, Colwill K, Gelband H, Birnboim HC, Nagelkerke N, Bogoch II, Bansal A, Newcombe L, Slater J, Rodriguez PS, Huang G, Fu SH, Meh C, Wu DC, Kaul R, Langlois M-A, Morawski E, Hollander A, Eliopoulos D, Aloi B, Lam T, Abe KT, Rathod B, Fazel-Zarandi M, Wang J, Iskilova M, Pasculescu A, Caldwell L, Barrios-Rodiles M, Mohammed-Ali Z, Vas N, Santhanam DR, Cho ER, Qu K, Jha S, Jha V, Suraweera W, Malhotra V, Mastali K, Wen R, Sinha S, Reid A, Gingras A-C, Chakraborty P, Slutsky AS, Jha P, Investigators A-CS. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults. JAMA Network Open. 2022;5(2):e2146798-e. doi: 10.1001/jamanetworkopen.2021.46798.

Tauzin A, Gong SY, Beaudoin-Bussières G, Vézina D, Gasser R, Nault L, Marchitto L, Benlarbi M, Chatterjee D, Nayrac M, Laumaea A, Prévost J, Boutin M, Sannier G, Nicolas A, Bourassa C, Gendron-Lepage G, Medjahed H, Goyette G, Bo Y, Perreault J, Gokool L, Morrisseau C, Arlotto P, Bazin R, Dubé M, De Serres G, Brousseau N, Richard J, Rovito R, Côté M, Tremblay C, Marchetti GC, Duerr R, Martel-Laferrière V, Kaufmann DE, Finzi A. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses. Cell Host & Microbe. 2022;30(1):97-109.e5. doi: 10.1016/j.chom.2021.12.004.

Tauzin A, Gong SY, Chatterjee D, Ding S, Painter MM, Goel RR, Beaudoin-Bussières G, Marchitto L, Boutin M, Laumaea A, Okeny J, Gendron-Lepage G, Bourassa C, Medjahed H, Goyette G, Williams JC, Bo Y, Gokool L, Morrisseau C, Arlotto P, Bazin R, Fafard J, Tremblay C, Kaufmann DE, De Serres G, Richard J, Côté M, Duerr R, Martel-Laferrière V, Greenplate AR, Wherry EJ, Finzi A. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses. Cell reports. 2022;41(4):111554. doi: 10.1016/j.celrep.2022.111554.

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. A Legal analysis of Vaccine Passports and Vaccine Mandates in the Private Sector. 2022. https://uploads-ssl.webflow.com/5e94a102877c872e8710b7a1/61dcdb1869bf179de6319152_A%20Legal%20Analysis%20of%20Vaccine%20Passports%20and%20Vaccine%20Mandates%20in%20the%20Private%20Sector.pdf

Tuite AR, Fisman D, Abe KT, Rathod B, Pasculescu A, Colwill K, Gingras AC, Yi QL, O’Brien SF, Drews SJ. Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays. Microbiol Spectr. 2022;10(1):e0256321. doi: 10.1128/spectrum.02563-21.

Ullah I, Beaudoin-Bussières G, Symmes K, Cloutier M, Ducas E, Tauzin A, Laumaea A, Bégin P, Mothes W, Kumar P, Bazin R, Finzi A, Uchil PD. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice. bioRxiv. 2022:2022.06.10.495677. doi: 10.1101/2022.06.10.495677.

Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, Sengupta A, Brassard JP, Guerra A, Dziarmaga R, Perez A, Sun Y, Li Y, Roussel L, Langelier MJ, Ke D, Arnold C, Whelan M, Pelchat M, Langlois MA, Zhang X, Mazer BD. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study. Lancet Healthy Longev. 2022;3(3):e166-e75. doi: 10.1016/s2666-7568(22)00012-5.

Walmsley S, Ravindran R, Clarke R, Wouters B, Silva A, Gingras A-C, Szadkowski L. COVID-19 breakthrough infections in vaccinated participants of the Safety and Efficacy of Preventative COVID Vaccines sub-study. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2022;7(4):333-42. doi: 10.3138/jammi-2022-0011.

Walmsley S, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A, Graham C, Silva A, Manase D, Parente L, Simpson J, Dayam RM, Pasculescu A, Gingras A-C. Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study. medRxiv. 2022:2022.02.09.22270734. doi: 10.1101/2022.02.09.22270734.

Watts AW, Hutchison SM, Bettinger JA, Gadermann A, Oberle E, Oberlander TF, Goldfarb DM, Lavoie PM, Mâsse LC. COVID-19 Vaccine Intentions and Perceptions Among Public School Staff of the Greater Vancouver Metropolitan Area, British Columbia, Canada. Frontiers in Public Health. 2022;10. doi: 10.3389/fpubh.2022.832444.

Watts AW, Mâsse LC, Goldfarb DM, Irvine MA, Hutchison SM, Muttucomaroe L, Poon B, Barakauskas VE, O’Reilly C, Bosman ES, Reicherz F, Coombs D, Pitblado M, O’Brien SF, Lavoie PM. SARS-CoV-2 seroprevalence among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada. medRxiv. 2022:2022.07.04.22277230. doi: 10.1101/2022.07.04.22277230.

Widdifield J, Eder L, Chen S, Kwong JC, Hitchon C, Lacaille D, Aviña-Zubieta JA, Svenson LW, Bernatsky S. COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis. J Rheumatol. 2022. doi: 10.3899/jrheum.211148.

Widdifield J, Kwong JC, Chen S, Eder L, Benchimol EI, Kaplan GG, Hitchon C, Aviña-Zubieta JA, Lacaille D, Chung H, Bernatsky S. Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis. Lancet Rheumatol. 2022. doi: 10.1016/s2665-9913(22)00096-0.

Williams C, Al-Bargash D, Macalintal C, Stuart R, Seth A, Latham J, Gitterman L, Fedsin S, Godoy M, Kozak R, Guthrie JL, Wood H, McGeer A, Hota S, Rea E. Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021. Clin Infect Dis. 2022;74(6):1085-8. doi: 10.1093/cid/ciab617.

Wilson M, Qiu Y, Yu J, Lee BE, McCarthy DT, Pang X. Comparison of Auto Sampling and Passive Sampling Methods for SARS-CoV-2 Detection in Wastewater. Pathogens. 2022;11(3). doi: 10.3390/pathogens11030359.

Wong MK, Liu JT, Budylowksi P, Yue FY, Li Z, Rini JM, Carlyle JR, Zia A, Ostrowski M, Martin A. Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine. Clinical Immunology. 2022;237:108963. doi: 10.1016/j.clim.2022.108963.

Yau K, Chan CT, Abe KT, Jiang Y, Atiquzzaman M, Mullin SI, Shadowitz E, Liu L, Kostadinovic E, Sukovic T, Gonzalez A, McGrath-Chong ME, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Levin A, Blake PG, Colwill K, Gingras AC, Hladunewich MA. Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis. CMAJ. 2022;194(8):E297-e305. doi: 10.1503/cmaj.211881.

Zhang A, Breznik JA, Clare R, Nazy I, Miller MS, Bowdish DME, Costa AP. Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents. J Am Med Dir Assoc. 2022;23(3):444-6. doi: 10.1016/j.jamda.2021.12.035.

Abe KT, Hu Q, Mozafarihashjin M, Samson R, Manguiat K, Robinson A, Rathod B, Hardy WR, Wang JH, Iskilova M, Pasculescu A, Fazel-Zarandi M, Li A, Paterson A, Chao G, Green K, Gilbert L, Barati S, Haq N, Takaoka A, Takaoka JG, De Launay KQ, Fahim C, Sheikh-Mohamed S, Arita Y, Durocher Y, Marcusson EG, Gommerman JL, Ostrowski M, Colwill K, Straus SE, Wood H, McGeer AJ, Gingras A-C. Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers. medRxiv. 2021:2021.08.06.21261721. doi: 10.1101/2021.08.06.21261721.

Anand SP, Prévost J, Nayrac M, Beaudoin-Bussières G, Benlarbi M, Gasser R, Brassard N, Laumaea A, Gong SY, Bourassa C, Brunet-Ratnasingham E, Medjahed H, Gendron-Lepage G, Goyette G, Gokool L, Morrisseau C, Bégin P, Martel-Laferrière V, Tremblay C, Richard J, Bazin R, Duerr R, Kaufmann DE, Finzi A. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell reports Medicine. 2021;2(6):100290. doi: 10.1016/j.xcrm.2021.100290.

Anand SP, Prévost J, Richard J, Perreault J, Tremblay T, Drouin M, Fournier MJ, Lewin A, Bazin R, Finzi A. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples. Transfusion. 2021;61(5):1377-82. doi: 10.1111/trf.16318.

Arora RK, Joseph A, Van Wyk J, Rocco S, Atmaja A, May E, Yan T, Bobrovitz N, Chevrier J, Cheng MP, Williamson T, Buckeridge DL. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. 2021;21(4):e75-e6. doi: 10.1016/s1473-3099(20)30631-9.

Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, Yanes-Lane M, Whelan M, Perlman-Arrow S, Chen J, Rahim H, Ilincic N, Segal M, Duarte N, Van Wyk J, Yan T, Atmaja A, Rocco S, Joseph A, Penny L, Clifton DA, Williamson T, Yansouni CP, Evans TG, Chevrier J, Papenburg J, Cheng MP. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PloS one. 2021;16(6):e0252617. doi: 10.1371/journal.pone.0252617.

Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. The Journal of infectious diseases. 2021;223(8):1334-8. doi: 10.1093/infdis/jiaa796.

Breznik JA, Zhang A, Huynh A, Miller MS, Nazy I, Bowdish DME, Costa AP. Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents. J Am Med Dir Assoc. 2021;22(12):2512-4. doi: 10.1016/j.jamda.2021.10.001.

Brockman MA, Mwimanzi F, Sang Y, Ng K, Agafitei O, Ennis S, Lapointe H, Young L, Umviligihozo G, Burns L, Brumme C, Leung V, Montaner JSG, Holmes D, DeMarco M, Simons J, Niikura M, Pantophlet R, Romney MG, Brumme ZL. Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine. medRxiv. 2021:2021.03.17.21253773. doi: 10.1101/2021.03.17.21253773.

Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, Sannier G, Orban C, Messier-Peet M, Butler-Laporte G, Morrison DR, Zhou S, Nakanishi T, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Bourassa C, Medjahed H, Laurent L, Rébillard RM, Richard J, Dubé M, Fromentin R, Arbour N, Prat A, Larochelle C, Durand M, Richards JB, Chassé M, Tétreault M, Chomont N, Finzi A, Kaufmann DE. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. 2021;7(48):eabj5629. doi: 10.1126/sciadv.abj5629.

Bryan Thomas CMF, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson. Are Vaccine Passports Discriminatory? CD Howe Institute. 2021. https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-wilson-%E2%80%93-are-vaccine-passports-discriminatory

Bryan Thomas CMF, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson. Four Privacy Choices for Vaccine Passports. CD Howe Institute. 2021. https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-and-wilson-%E2%80%93-four-privacy-choices-vaccine

Cao H, Mai J, Zhou Z, Li Z, Duan R, Watt J, Chen Z, Bandara RA, Li M, Ahn SK, Poon B, Christie-Holmes N, Gray-Owen SD, Banerjee A, Mossman K, Kozak R, Mubareka S, Rini JM, Hu J, Liu J. Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2. Cell Biosci. 2021;11(1):202. doi: 10.1186/s13578-021-00723-0.

Castonguay N, Zhang W, Langlois MA. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2. Front Microbiol. 2021;12:676314. doi: 10.3389/fmicb.2021.676314.

Charlton CL, Nguyen LT, Bailey A, Fenton J, Plitt SS, Marohn C, Lau C, Hinshaw D, Lutsiak C, Simmonds K, Kanji JN, Zelyas N, Lee N, Mengel M, Tipples G. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic. Microbiol Spectr. 2021;9(1):e0029121. doi: 10.1128/Spectrum.00291-21.

Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, Galipeau Y, Langlois MA, Gingras AC, Yansouni CP, Papenburg J, Cheng MP, Chakraborty P, Stein DR, Van Caeseele P, Bartlett S, Krajden M, Goldfarb D, McGeer A, Osiowy C, Hankins C, Mazer B, Drebot M, Kim J. Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison. PloS one. 2021;16(12):e0261003. doi: 10.1371/journal.pone.0261003.

Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study. BMJ. 2021;374:n1943. doi: 10.1136/bmj.n1943.

Costa AP, Manis DR, Jones A, Stall NM, Brown KA, Boscart V, Castellino A, Heckman GA, Hillmer MP, Ma C, Pham P, Rais S, Sinha SK, Poss JW. Risk factors for outbreaks of SARS-CoV-2 infection at retirement homes in Ontario, Canada: a population-level cohort study. CMAJ. 2021;193(19):E672-e80. doi: 10.1503/cmaj.202756.

Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open. 2021;11(12):e054208. doi: 10.1136/bmjopen-2021-054208.

D’Aoust PM, Towhid ST, Mercier É, Hegazy N, Tian X, Bhatnagar K, Zhang Z, Naughton CC, MacKenzie AE, Graber TE, Delatolla R. COVID-19 wastewater surveillance in rural communities: Comparison of lagoon and pumping station samples. Sci Total Environ. 2021;801:149618. doi: 10.1016/j.scitotenv.2021.149618.

Demone J, Nourimand M, Maltseva M, Nasr-Sharif M, Galipeau Y, Langlois M-A, MacLean AM. Plant-based production of SARS-CoV-2 antigens for use in a subunit vaccine. bioRxiv. 2021:2021.10.17.464700. doi: 10.1101/2021.10.17.464700.

Duarte N, D’Mello S, Duarte NA, Rocco S, Van Wyk J, Pillai AA, Liu M, Williamson T, Arora RK. Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021. medRxiv. 2021:2021.06.29.21259730. doi: 10.1101/2021.06.29.21259730.

Ferreira VH, Marinelli T, Ierullo M, Ku T, Hall VG, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients. The Journal of infectious diseases. 2021;224(11):1849-60. doi: 10.1093/infdis/jiab542.

Flood CM, Thomas B, Wilson K. Mandatory vaccination for health care workers: an analysis of law and policy. CMAJ. 2021;193(6):E217-e20. doi: 10.1503/cmaj.202755.

Galipeau Y, Siragam V, Laroche G, Marion E, Greig M, McGuinty M, Booth RA, Durocher Y, Cuperlovic-Culf M, Bennett SAL, Crawley AM, Giguère PM, Cooper C, Langlois MA. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2. EBioMedicine. 2021;74:103700. doi: 10.1016/j.ebiom.2021.103700.

Gasser R, Cloutier M, Prévost J, Fink C, Ducas É, Ding S, Dussault N, Landry P, Tremblay T, Laforce-Lavoie A, Lewin A, Beaudoin-Bussières G, Laumaea A, Medjahed H, Larochelle C, Richard J, Dekaban GA, Dikeakos JD, Bazin R, Finzi A. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell reports. 2021;34(9):108790. doi: 10.1016/j.celrep.2021.108790.

Graber TE, Mercier É, Bhatnagar K, Fuzzen M, D’Aoust PM, Hoang HD, Tian X, Towhid ST, Plaza-Diaz J, Eid W, Alain T, Butler A, Goodridge L, Servos M, Delatolla R. Near real-time determination of B.1.1.7 in proportion to total SARS-CoV-2 viral load in wastewater using an allele-specific primer extension PCR strategy. Water Res. 2021;205:117681. doi: 10.1016/j.watres.2021.117681.

Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O’Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM. A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval. Clin Infect Dis. 2021. doi: 10.1093/cid/ciab938.

Hall VG, Ferreira VH, Ierullo M, Ku T, Marinelli T, Majchrzak-Kita B, Yousuf A, Kulasingam V, Humar A, Kumar D. Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2021;21(12):3980-9. doi: 10.1111/ajt.16766.

Hasing M, Yu J, Qiu Y, Maal-Bared R, Bhavanam S, Lee B, Hrudey S, Pang X. Comparison of Detecting and Quantitating SARS-CoV-2 in Wastewater Using Moderate-Speed Centrifuged Solids versus an Ultrafiltration Method. Water. 2021;13(16):2166. doi: 10.3390/w13162166.

Hogan CA, Jassem AN, Sbihi H, Joffres Y, Tyson JR, Noftall K, Taylor M, Lee T, Fjell C, Wilmer A, Galbraith J, Romney MG, Henry B, Krajden M, Galanis E, Prystajecky N, Hoang LMN. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021. Emerg Infect Dis. 2021;27(11):2802-9. doi: 10.3201/eid2711.211190.

Huynh A, Arnold DM, Smith JW, Moore JC, Zhang A, Chagla Z, Harvey BJ, Stacey HD, Ang JC, Clare R, Ivetic N, Chetty VT, Bowdish DME, Miller MS, Kelton JG, Nazy I. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 2021;13(4). doi: 10.3390/v13040697.

Investigators AtbcApblcS, Jha P. COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada. medRxiv. 2021:2021.03.04.21252540. doi: 10.1101/2021.03.04.21252540.

Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS pathogens. 2021;17(12):e1010092. doi: 10.1371/journal.ppat.1010092.

Kinloch NN, Ritchie G, Dong W, Cobarrubias KD, Sudderuddin H, Lawson T, Matic N, Montaner JSG, Leung V, Romney MG, Lowe CF, Brumme CJ, Brumme ZL. SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR. The Journal of molecular diagnostics : JMD. 2021;23(8):907-19. doi: 10.1016/j.jmoldx.2021.04.014.

Law JC, Koh WH, Budylowski P, Lin J, Yue F, Abe KT, Rathod B, Girard M, Li Z, Rini JM, Mubareka S, McGeer A, Chan AK, Gingras AC, Watts TH, M AO. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile. Journal of immunology (Baltimore, Md : 1950). 2021;206(1):37-50. doi: 10.4049/jimmunol.2001067.

Lee BE, Sikora C, Faulder D, Risling E, Little LA, Qiu Y, Gao T, Bulat R, Craik S, Hrudey SE, Ohinmaa A, Estabrooks CA, Gingras AC, Charlton C, Kim J, Wood H, Robinson A, Kanji JN, Zelyas N, O’Brien SF, Drews S, Pang XL. Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol. BMJ Open. 2021;11(8):e052282. doi: 10.1136/bmjopen-2021-052282.

Li X, Vanderloo LM, Maguire JL, Keown-Stoneman CDG, Aglipay M, Anderson LN, Cost KT, Charach A, Vanderhout SM, Birken CS. Public health preventive measures and child health behaviours during COVID-19: a cohort study. Can J Public Health. 2021;112(5):831-42. doi: 10.17269/s41997-021-00549-w.

Liu Y, Budylowski P, Dong S, Li Z, Goroshko S, Leung LYT, Grunebaum E, Campisi P, Propst EJ, Wolter NE, Rini JM, Zia A, Ostrowski M, Ehrhardt GRA. SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals. Journal of immunology (Baltimore, Md : 1950). 2021;207(10):2581-8. doi: 10.4049/jimmunol.2100606.

Madathil S, Siqueira WL, Marin LM, Sanaulla FB, Faraj N, Quiñonez CR, McNally M, Glogauer M, Allison P. The incidence of COVID-19 among dentists practicing in the community in Canada: A prospective cohort study over a six-month period. The Journal of the American Dental Association. 2021. doi: 10.1016/j.adaj.2021.10.006.

Majdoubi A, Michalski C, O’Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler DF, Basappa M, Liu AC, Görges M, Barakauskas VE, Irvine M, Mehalko J, Esposito D, Sekirov I, Jassem AN, Goldfarb DM, Pelech S, Douek DC, McDermott AB, Lavoie PM. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI insight. 2021;6(8). doi: 10.1172/jci.insight.146316.

Matic N, Lowe CF, Ritchie G, Stefanovic A, Lawson T, Jang W, Young M, Dong W, Brumme ZL, Brumme CJ, Leung V, Romney MG. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada. Emerg Infect Dis. 2021;27(6):1673-6. doi: 10.3201/eid2706.210532.

McKinnon B, Quach C, Dubé È, Tuong Nguyen C, Zinszer K. Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada. Vaccine. 2021;39(49):7140-5. doi: 10.1016/j.vaccine.2021.10.077.

McRae AD, Hohl CM, Rosychuk R, Vatanpour S, Ghaderi G, Archambault PM, Brooks SC, Cheng I, Davis P, Hayward J, Lang E, Ohle R, Rowe B, Welsford M, Yadav K, Morrison LJ, Perry J. CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19. BMJ Open. 2021;11(12):e055832. doi: 10.1136/bmjopen-2021-055832.

Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 2021;11(12):e052019. doi: 10.1136/bmjopen-2021-052019.

Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. Journal of thrombosis and haemostasis : JTH. 2021;19(5):1342-7. doi: 10.1111/jth.15283.

Papenburg J, Cheng MP, Corsini R, Caya C, Mendoza E, Manguiat K, Lindsay LR, Wood H, Drebot MA, Dibernardo A, Zaharatos G, Bazin R, Gasser R, Benlarbi M, Gendron-Lepage G, Beaudoin-Bussières G, Prévost J, Finzi A, Ndao M, Yansouni CP. Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay. Open Forum Infect Dis. 2021;8(6):ofab220. doi: 10.1093/ofid/ofab220.

Rais Y, Fu Z, Drabovich AP. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants. Clin Proteomics. 2021;18(1):19. doi: 10.1186/s12014-021-09325-x.

Rébillard RM, Charabati M, Grasmuck C, Filali-Mouhim A, Tastet O, Brassard N, Daigneault A, Bourbonnière L, Anand SP, Balthazard R, Beaudoin-Bussières G, Gasser R, Benlarbi M, Moratalla AC, Solorio YC, Boutin M, Farzam-Kia N, Descôteaux-Dinelle J, Fournier AP, Gowing E, Laumaea A, Jamann H, Lahav B, Goyette G, Lemaître F, Mamane VH, Prévost J, Richard J, Thai K, Cailhier JF, Chomont N, Finzi A, Chassé M, Durand M, Arbour N, Kaufmann DE, Prat A, Larochelle C. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients. J Clin Invest. 2021;131(8). doi: 10.1172/jci145853.

Saeed S, Drews SJ, Pambrun C, Yi QL, Osmond L, O’Brien SF. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Transfusion. 2021;61(3):862-72. doi: 10.1111/trf.16296.

Saeed S, O’Brien SF, Abe K, Yi QL, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras AC, Drews SJ. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PloS one. 2021;16(9):e0257743. doi: 10.1371/journal.pone.0257743.

Shire ZJ, Reicherz F, Lawrence S, Sudan H, Golding L, Majdoubi A, Levett PN, Lavoie PM, Jacobson K. Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy. Gut. 2021. doi: 10.1136/gutjnl-2021-326196.

Tang X, Gelband H, Nagelkerke N, Bogoch II, Brown P, Morawski E, Lam T, Jha P. COVID-19 vaccination intention during early vaccine rollout in Canada: a nationwide online survey. The Lancet Regional Health – Americas. 2021;2:100055. doi: 10.1016/j.lana.2021.100055.

Tanner R, Flood CM. Vaccine Passports Done Equitably. JAMA Health Forum. 2021;2(4):e210972-e. doi: 10.1001/jamahealthforum.2021.0972.

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. Vaccine Ins and Outs: An Exploration of the Legal Issues Raised by Vaccine Passports. CD Howe Institute. 2021. https://www.cdhowe.org/public-policy-research/vaccine-ins-and-outs-exploration-legal-issues-raised-vaccine-passports

Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Symmes K, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, Bourassa C, Medjahed H, Mack M, Chung K, Wilen CB, Dekaban GA, Dikeakos JD, Bruce EA, Kaufmann DE, Stamatatos L, McGuire AT, Richard J, Pazgier M, Bjorkman PJ, Mothes W, Finzi A, Kumar P, Uchil PD. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. 2021;54(9):2143-58.e15. doi: 10.1016/j.immuni.2021.08.015.

Wilson K, Flood CM. Implementing digital passports for SARS-CoV-2 immunization in Canada. CMAJ. 2021;193(14):E486-e8. doi: 10.1503/cmaj.210244.

Yau K, Abe KT, Naimark D, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Mullin SI, Shadowitz E, Gonzalez A, Sukovic T, Garnham-Takaoka J, de Launay KQ, Takaoka A, Straus SE, McGeer AJ, Chan CT, Colwill K, Gingras AC, Hladunewich MA. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis. JAMA Netw Open. 2021;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622.

Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, Laurent L, Pietzner M, Kerrison N, Zhao K, Brunet-Ratnasingham E, Henry D, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Chen Y, Chassé M, Durand M, Paterson C, Normark J, Frithiof R, Lipcsey M, Hultström M, Greenwood CMT, Zeberg H, Langenberg C, Thysell E, Pollak M, Mooser V, Forgetta V, Kaufmann DE, Richards JB. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27(4):659-67. doi: 10.1038/s41591-021-01281-1.

Zinszer K, McKinnon B, Bourque N, Pierce L, Saucier A, Otis A, Cheriet I, Papenburg J, Hamelin M-È, Charland K, Carbonneau J, Zahreddine M, Savard A, Fortin G, Apostolatos A, Haley N, Ratté N, Laurin I, Nguyen CT, Conrod P, Boivin G, De Serres G, Quach C. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada. JAMA Network Open. 2021;4(11):e2135975-e. doi: 10.1001/jamanetworkopen.2021.35975.

Zinszer K, McKinnon B, Bourque N, Zahreddine M, Charland K, Papenburg J, Fortin G, Hamelin M, Saucier A, Apostolatos A, Pierce L, Savard-Lamothe A, Carbonneau J, Conrod P, Haley N, Laurin I, Boivin G, De Serres G, Quach C. Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada. BMJ Open. 2021;11(7):e053245. doi: 10.1136/bmjopen-2021-053245.

Anand SP, Chen Y, Prévost J, Gasser R, Beaudoin-Bussières G, Abrams CF, Pazgier M, Finzi A. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins. Viruses. 2020;12(10). doi: 10.3390/v12101104.

Beaudoin-Bussières G, Laumaea A, Anand SP, Prévost J, Gasser R, Goyette G, Medjahed H, Perreault J, Tremblay T, Lewin A, Gokool L, Morrisseau C, Bégin P, Tremblay C, Martel-Laferrière V, Kaufmann DE, Richard J, Bazin R, Finzi A. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals. mBio. 2020;11(5). doi: 10.1128/mBio.02590-20.

Colleen M. Flood VK, Kumanan Wilson Please show your vaccination certificate. Policy Options. 2020. doi, https://policyoptions.irpp.org/magazines/december-2020/please-show-your-vaccination-certificate/

Ding S, Laumaea A, Benlarbi M, Beaudoin-Bussières G, Gasser R, Medjahed H, Pancera M, Stamatatos L, McGuire AT, Bazin R, Finzi A. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization. Viruses. 2020;12(11). doi: 10.3390/v12111214.

Lu M, Uchil PD, Li W, Zheng D, Terry DS, Gorman J, Shi W, Zhang B, Zhou T, Ding S, Gasser R, Prévost J, Beaudoin-Bussières G, Anand SP, Laumaea A, Grover JR, Liu L, Ho DD, Mascola JR, Finzi A, Kwong PD, Blanchard SC, Mothes W. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020;28(6):880-91.e8. doi: 10.1016/j.chom.2020.11.001.

Perreault J, Tremblay T, Fournier MJ, Drouin M, Beaudoin-Bussières G, Prévost J, Lewin A, Bégin P, Finzi A, Bazin R. Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset. Blood. 2020;136(22):2588-91. doi: 10.1182/blood.2020008367.

Prévost J, Gasser R, Beaudoin-Bussières G, Richard J, Duerr R, Laumaea A, Anand SP, Goyette G, Benlarbi M, Ding S, Medjahed H, Lewin A, Perreault J, Tremblay T, Gendron-Lepage G, Gauthier N, Carrier M, Marcoux D, Piché A, Lavoie M, Benoit A, Loungnarath V, Brochu G, Haddad E, Stacey HD, Miller MS, Desforges M, Talbot PJ, Maule GTG, Côté M, Therrien C, Serhir B, Bazin R, Roger M, Finzi A. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell reports Medicine. 2020;1(7):100126. doi: 10.1016/j.xcrm.2020.100126.

Van Caeseele P, Bailey D, Forgie SE, Dingle TC, Krajden M. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health. CMAJ. 2020;192(34):E973-e9. doi: 10.1503/cmaj.201588.

Perreault J, Tremblay T, Fournier MJ, Drouin M, Beaudoin-Bussières G, Prévost J, Lewin A, Bégin P, Finzi A, Bazin R. Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset. Blood. 2020;136(22):2588-91. doi: 10.1182/blood.2020008367.

Prévost J, Gasser R, Beaudoin-Bussières G, Richard J, Duerr R, Laumaea A, Anand SP, Goyette G, Benlarbi M, Ding S, Medjahed H, Lewin A, Perreault J, Tremblay T, Gendron-Lepage G, Gauthier N, Carrier M, Marcoux D, Piché A, Lavoie M, Benoit A, Loungnarath V, Brochu G, Haddad E, Stacey HD, Miller MS, Desforges M, Talbot PJ, Maule GTG, Côté M, Therrien C, Serhir B, Bazin R, Roger M, Finzi A. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell reports Medicine. 2020;1(7):100126. doi: 10.1016/j.xcrm.2020.100126.

Van Caeseele P, Bailey D, Forgie SE, Dingle TC, Krajden M. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health. CMAJ. 2020;192(34):E973-e9. doi: 10.1503/cmaj.201588.

Reports from CITF-funded research

Canadian Blood Services. COVID-19 Seroprevalence Report. 2024 Jan 09. Report No.: 40: November 2023 Survey  

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Dec 03. Report No.: 39: October 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Nov 01. Report No.: 38: September 2023 Survey

Zinszer K. Encore study – Preliminary results. 2023 Oct 11. Report No.: 5

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Sep 29. Report No.: 37: August 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Aug 28. Report No.: 36: July 2023

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Jul 28. Report No.: 35: June 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. Canadian Blood Services; 2023 Jun 28. Report No.: 34: May 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Jun 08. Report No.: 33: April 2023 Survey

Canadian Blood Services. COVID-19 Sereprevalence Report. 2023 Jun 02. Report No.: 32: March 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2023 Apr 27. Report No.: 32A: March 1-15, 2023, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Apr 05. Report No.: 31: February, 2023 Survey

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2023 Mar 08. Report No.: 31A: February 1-14, 2023, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Mar 02. Report No.: 30: January 2023 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2023 Feb 15. Report No.: 30A: January 1-15, 2023, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Feb 02. Report No.: 29: December 2022 Survey

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2023 Jan 17. Report No.: 29A: December 1-15, 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2023 Jan 06. Report No.: 28: November 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Dec 15. Report No.: 28A: November 1-15, 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Dec 02. Report No.: 27: October 2022 Survey – The advance of Omicron

Zinszer K. Encore Study – Preliminary results. 2022 Nov 25. Report No.: 4

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Nov 23. Report No.: 27A: October 1-15, 2022

Héma-Québec. Phase 4b of the study on the seroprevalence of antibodies to SARS-CoV-2 in Quebec. 2022 Nov 22. Report No.: 4b and addendum

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario Ottawa, ON; 2022 Nov 21. Report No.: 6: December 14, 2020 to September 30, 2022  https://www.bornontario.ca/en/whats-happening/resources/Documents/COVID-19-Vaccination-during-pregnancy-in-Ontario_Report6.pdf.

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Nov 07. Report No.: 26: September 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Sep 29. Report No.: 25: August 2022 Survey – The advance of Omicron

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario Ottawa, ON; 2022 Sep 26. Report No.: 5: December 14, 2020 to May 31, 2022  https://www.bornontario.ca/en/whats-happening/resources/Documents/COVID-19-Vaccination-during-pregnancy-in-Ontario_Report_Dec2020-May2022.pdf.

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Sep 24. Report No.: 26A: September 1-14, 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence report. 2022 Aug 25. Report No.: 24: July 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Aug 03. Report No.: 23: June 2022 Survey – The advance of Omicron

Héma-Québec. Phase 4b of the study on the seroprevalence of antibodies tp SARS-CoV-2 in Quebec. 2022 Jul 15. Report No.: 4b

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Jun 23. Report No.: 22: May 2022 Survey – The advance of Omicron

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario. Ottawa, ON; 2022 Jun 15. Report No.: 4: December 14, 2020 to March 31, 2022. https://www.bornontario.ca/en/whats-happening/resources/Documents/COVID-19-Vaccination-during-pregnancy-in-Ontario_Report_third-dose_FINAL.pdf.

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Jun 12. Report No.: 22A: May 1-15 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Jun 03. Report No.: 21: April 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 May 17. Report No.: 21A: April 1-15, 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 May 06. Report No.: 20: March 2022 Survey – The advance of Omicron

Héma-Québec. Phase 4 de l’étude sur la séroprévalence des anticorps dirigés contre le SRAS-CoV-2 au Québec. 2022 May 05. Report No.: 4

Zinszer K. Encore Study – Preliminary Results. 2022 May 02. Report No.: 3

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Apr 22. Report No.: 20A: March 1-15, 2022 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Apr 10. Report No.: 19: February 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Mar 23. Report No.: 19A: February 1-15, 2022 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Mar 12. Report No.: 16: November 2021 Survey – Tracking seroprevalence in the vaccine era

Canadian Blood Services. COVD-19 Seroprevalence Report. 2022 Mar 12. Report No.: 17: December 2021 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Mar 11. Report No.: 18: January 2022 Survey – The advance of Omicron

Canadian Blood Services. COVID-19 Seroprevalence Brief Report. 2022 Feb 23. Report No.: 18A: January 1-15, 2022, Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2022 Jan 03. Report No.: 15: October 2021 Survey – Tracking seroprevalence in the vaccine era

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Nov 30. Report No.: 14: September 2021 Survey – Tracking seroprevalence in the vaccine era

Héma-Québec. Phase 3 de l’étude sur la séroprévalence des anticorps dirigés contre le SRAS-CoV-2 au Québec. 2021 Nov 18. Report No.: 3

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Oct 27. Report No.: 13: August 2021 Survey – Tracking seroprevalence in the vaccine era

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Oct 13. Report No.: 12: July 2021 Survey – Tracking seroprevalence in the vaccine era

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario. Ottawa, ON; 2021 Oct 01. Report No.: 3: Reporting Interval December 14, 2020 to September 30, 2021  https://www.bornontario.ca/en/whats-happening/covid-19-vaccination-during-pregnancy-in-ontario.aspx.

Zinszer K. Encore Study – Preliminary results. 2021 Oct 01. Report No.: 2

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Aug 30. Report No.: 11: June 2021 Survey – Tracking seroprevalence in the vaccine era

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario Ottawa, ON; 2021 Jul 30. Report No.: 2: Reporting Interval December 14, 2020 to June 30, 2021  https://www.bornontario.ca/en/whats-happening/resources/Documents/BORN-COVID-19-Vaccination-During-Pregnancy-in-Ontario-Report-2—FINAL.pdf.

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Jul 27. Report No.: 10: May 2021 Survey -Tracking seroprevamence in the vaccine era

Canadian Blood Services. COVID-19 Vaccine Survey. 2021 Jun 30.

Better Outcomes Registry & Network (BORN) Ontario. COVID-19 Vaccination During Pregnancy in Ontario. Ottawa, ON; 2021 Jun 30. Report No.: 1: Reporting Interval December 14, 2020 to May 31, 2021  https://www.bornontario.ca/en/whats-happening/covid-19-vaccination-during-pregnancy-in-ontario.aspx.

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Jun 30. Report No.: 9: April 2021 Survey

Héma-Québec. Phase 2 de l’étude sur la séroprévalence des anticorps dirigés contre le SRAS-CoV-2 au Québec. 2021 Jun 11. Report No.: 2

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Jun 9. Report No.: 8: March 2021 Survey – Tracking seroprevalence in the vaccine era

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 May 10. Report No.: 7: January 2021 Survey – Monitoring immunity in the vaccine era

Canadian Blood Services. COVID-19 Public Seroprevalence Report. 2021 May 10. Report No.: Public Report –  April 2020 to January 2021

Zinszer K. Encore Study – Preliminary results. 2021 May 03. Report No.: 1

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Mar 18. Report No.: 6: January 2021 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Feb 8. Report No.: 5: December 2020 Survey

Héma-Québec. Étude de séroprévalence des anti-SRAS-CoV-2 chez les donneurs de sang d’Héma-Québec, vers la fin de la première vague de COVID-19. 2021 Jan 21. Report No.: 1

Canadian Blood Services. COVID-19 Seroprevalence Report. 2021 Jan 12. Report No.: 4: November 2020 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2020 Dec 18. Report No.: 3: October 2020 Survey

Canadian Blood Services. COVID-19 Seroprevalence Report. 2020 Oct 20. Report No.: 2: Samples collected from May 9 to July 21 2020

Canadian Blood Services. COVID-19 Seroprevalence Report. 2020 Aug 19. Report No.: 1: Samples collected from May 9-June 18 2020

Canadian Blood Services. COVID-19 Public Seroprevalence Report. 2020 Aug 19. Report No.: Public Report

Go to Top